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Hantaviruses are enveloped RNA viruses belong to the Family Bunyaviridae, 
which cause hemorrhagic fever with renal syndrome (HFRS) and hantavirus 
cardiopulmonary syndrome (HCPS) in humans. The hantavirus genome consists of 
three negative-strand RNA segments, S, M and L, which encodes nucleocapsid 
protein (N), glycoprotein precursor (GPC), RNA-dependent RNA polymerase (RdRp), 
and in some genus, a non-structural protein (NSs). 
Hantaviruses initiate transcription by cap-snatching mechanism. Host mRNAs 
are processed by viral RNP and used as primers for transcription initiation. N proteins 
protect those cap donors and enrich them in P-bodies. We showed that in P-body 
deficient cells, capped oligos were also protected but not effectively used, suggesting 
that caps concentrated within P-bodies are preferred for cap-snatching. We also 
characterized the determinants for a capped transcript to be an efficient cap donor 
using test transcripts. We showed hantavirus more efficiently snatches caps from 
mRNAs not engaged in translation and the hantavirus RNP preferentially cleaves the 
cap donor mRNA after the G residue located 14 nucleotides from 5’ cap. Moreover, 
better sequence complementarity between the 3’ terminus of vRNA and cap donor 
favors cap-snatching. These results indicate hantavirus snatches caps from non-
translating mRNA, and the viral RNP may recognize and process host-capped oligos 
based on position and complementarity of the annealing between to vRNA and 
capped oligos.  
We also explored requirement of other viral proteins for RdRp function. We 
found N protein interacts with RdRp in virus-infected cells. We mapped the RdRp 
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binding domain to the N-terminal region of the N that excluded the RNA binding 
domain. Similarly, the N-binding pocket is located at the C-terminus of RdRp. We 
demonstrate that an N-RdRp interaction is required for RdRp function during the 
course of virus infection in the host cell. 
Taken together, we characterized the preferred capped primer used for 
efficient cap-snatching. We also provided insights to the specificity of the hantavirus 
RdRp endonuclease, by showing N-RdRp interaction in the absence of RNA binding 
domain. Our findings have provided insight into the understanding of the mechanism 
hantavirus cap-snatching and will shed light on the identification of anti-viral targets 
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1. Hantaviruses and function of hantaviral proteins 
Hantaviruses are negative-strand RNA viruses that belong to the family 
Bunyaviridae. Unlike other members in the family, which are carried by 
arthropods, hantaviruses are primarily rodent-borne. As of 2012, twenty-four 
hantavirus species have been discovered and based on their phylogenetic 
characteristics, have been divided into three clusters: Non-pathogenic viruses, 
hemorrhagic fever with renal syndrome (HFRS)-causing viruses, and hantavirus 
cardiopulmonary syndrome (HCPS)-causing viruses. The natural reservoir hosts 
of hantaviruses include rodents, shrews, moles and bats, and the pathogenic 
viruses can cause human diseases by transmitting via aerosolized rodent 
excreta. [1-3] Although person-to-person transmission of Andes virus (ANDV) 
has been reported [4] and blood transmission of Puumala virus has been 
documented[5]. Thus, the epidemics caused by hantaviruses are closely linked to 
the population dynamics of the rodent carriers in the certain geographical area. 
For example, the old world hantaviruses, Hantaan virus and Puumala virus are 
distributed in Asia and Europe respectively, whereas the new world hantavirus, 
Sin Nombre virus and Andes viruses, are only found in Americas. Interestingly, 
the pathogenic hantaviruses do not cause visible disease in rodents with the 
exception of ANDV. [6] 
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1.1 Diseases caused by hantavirus infection 
In humans, pathogenic hantaviruses cause two acute diseases: 
Hemorrhagic fever with renal syndrome (HFRS) and Hantavirus cardiopulmonary 
syndrome (HCPS). HFRS is primarily caused by Hantaan virus (HTNV), Puumala 
virus (PUUV), Dobrava virus (DOBV) and Seoul virus (SEOV). This disease has 
a mortality of around 10% with renal specific infection indicated by proteinuria, 
hematuria and acute kidney injury [1-3, 7]. The course of the HFRS is highly 
variable and depending on the hantavirus genotype. However, most patients 
recover from the infection. On the other hand, HCPS is a more severe disease 
that results in pulmonary oedema and cardiogenic shock [8]. Myalgia, cough and 
diarrhea are more commonly present in HCPS than in HFRS [8, 9]. In some of 
the HCPS-causing hantaviruses, hemorrhagic and renal syndrome also presents 
alongside [9]. The mortality of HCPS is up to 40% [3, 8, 9]. In either disease, 
cytopathic effect of the virus has not been observed [1, 10]. Pathogenesis of 
hantavirus related disease appears to be closely related to β3 integrin, which is 
one of the cell surface receptor for pathogenic hantaviruses [10]. A common 
pathological characteristic of both HFRS and HCPS, hyperpermeability of the 
capillaries is thought be a result of β3 integrin inactivation [11-13]. This viral 
induced inactivation causes deregulation of VEGF receptor 2 (VEGFR2) on the 
vascular endothelial cell surface [10], which leads to the up-regulation of vascular 
endothelial growth factor A (VEGFA) followed by down-regulation of VE-cadherin 
down-regulation [10, 14, 15]. VE-cadherin is essential for the formation of 
endothelial tight junction and the loss of VE-cadherin results in loosen of cell 
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junction thus increased vascular permeability. The hemorrhaging associated with 
the infection is caused by viral induced thrombocytopenia and is also related to 
the deregulation of β3 integrins [7, 11, 12]. Although the mechanism of viral 
induced thrombocytopenia is still unknown, it has been suggested that infected 
endothelial cells may attach to quiescent platelets through interaction between 
hantavirus glycoproteins and the integrin αIIβ3 on the platelet surface [16]. In 
addition to vascular endothelial cells, hantaviruses can also infect tubular 
epithelial cells, glomerular endothelial cells and podocytes of the glomeruli in the 
human kidneys, leading to the disruption of cell junctions through ZO-1. This 
disruption might be the cause of renal manifestations observed during HFRS 
[17]. 
 
1.2 Hantavirus particle and viral proteins 
The hantavirus particles are enveloped, around 120nm-160nm in 
diameter. The genome of hantavirus consists of three negative RNA segments 
that encapsidated by nucleocapsid proteins and contained inside the envelope 
[18, 19]. (Fig. 1A and B) Each segment of the viral RNA (vRNA) consists of an 
open reading frame (ORF) flanked by untranslated regions (UTRs) at both 3’ and 
5’ terminus.(Fig. 1C) The terminus of each UTR contains a highly conserved 
nucleotides that are complimentary to each other to form a panhandle structure 
which thought to be important for transcription and replication[20, 21]. The ORF 
from S, M and L RNA segments encodes for nucleocapsid (N) protein, 
glycoprotein precursor (GPC) and RNA-dependent RNA polymerase (RdRp), 
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respectively. GPC undergoes co-translational cleavage to form Gn and Gc. In 
some hantavirus species, a small non-structure protein, NSs, is also encoded 
from the S-segment through an alternative ORF.  (Fig. 1C) 
Nucleocapsid protein, N 
The nucleocapsid protein (N) is the most abundant protein in the virus. It 
plays a central role in the life cycle of the hantavirus. [22] N protein contains a 
highly conserved RNA binding motif that enables N protein to encapsidate the 
viral RNAs to form vRNPs.[23] In addition, as more functions of N protein are 
being revealed, the N protein has been suggested to be a multifunctional protein 
that regulates both viral and host functions such as cell survival, immune 
suppression, viral translation and replication as well as viral assembly.  
The, N protein plays a crucial role in modulating apoptosis in the infected cells; it 
has been demonstrated to inhibit apoptosis induced by Daxx and SUMO-1 
pathway through direct interaction [24-27] with Daxx and SUMO-1, respectively. 
In addition, a recent study also revealed that N protein inhibits the enzymatic 
activity of both granzyme B and caspase-3, which makes hantavirus infected 
cells resistant to cytotoxic lymphocyte-mediated apoptosis [28]. Second, the N 
protein also antagonizes host antiviral signaling by sequestrating the NF-κB in 
the cytoplasm [29]. Moreover, it has also been revealed recently that N protein 
from ANDV inhibits RIG-I/MDA5 mediated IFN signaling by interfering with TBK1 
activation [30].  
Third, the N protein is also able to regulate cellular mRNA translation and 
degradation apparatus. N protein has been shown to have a cap-binding domain 
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that enables N to bind host mRNA on cap and functionally replace the cellular 
eIF4F in the translation initiation complex to load the 40S ribosome to the N 
protein bound mRNA by directly interacting with the ribosomal subunit S19 [31-
33] . Moreover, N also specifically enhances translation of the viral transcripts 
over the host in cis by recognizing and binding to the triplet UAG repeats on the 
5’ UTR of the viral mRNA with a higher affinity [34]. The N protein is also 
suggested to be the major actor on switching between mRNA transcription and 
genome replication through its RNA chaperone activity [35, 36]. The N protein of 
SNV is found to co-localized with cellular processing bodies (P-bodies), where 
host RNAs are sequestered and degraded. The stability of mRNAs that are 
targeted for degradation has been shown to increase either in the presence of N 
protein or during hantavirus infection [37].  
Finally, N protein might also be crucial for initiation of virus assembly. In 
support of the idea, N protein has been shown to interact with the cytoplasmic tail 
of glycoprotein Gn, and nucleocapsid protein is able to stabilize Gn from 
autophagic clearance inside infected cell at later stages of viral infection. [38-40] 
In summary, hantavirus N protein performs different functions at different stages 
of the virus life cycle to facilitate propagation of the virus. 
 
Glycoproteins, Gn and Gc 
When expressed in the infected cells, the glycoprotein precursor is co-
traslationally cleaved at a conserved WAASA motif by the cellular protease, 
yielding Gn and Gc. Both Gn and Gc have transmemberane domains and they 
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form heterodimers that protrude from the viral envelope [41-44]. During viral 
infection, the function of glycoproteins has been proposed to be important for 
receptor signaling and internalization. In support, the C-terminal tail of the Gn 
protein contains one or more conserved YxxL motifs that are known to direct 
receptor signaling within immune and endothelial cells [45]. Moreover, 
bioinformatics studies suggested that ANDV Gc protein is a fusion protein that 
may direct the viral fusion activity [46]. 
Several studies now suggest that Gn is important for viral assembly [39, 
40, 47]. First, Gn was found to be degraded by autophagy at early stages of viral 
life cycle [40]. Second, Gn tails form a CCHC-type zinc finger which binds RNA 
or to each other [47]. And third, Gn is stabilized when N is accumulated in the 
cells at later stage of the viral life cycle and the cytoplasmic tail of Gn specifically 
interacts with N protein [39]. 
 
RNA-dependent RNA-Polymerase, (L-protein) 
RNA-dependent RNA polymerase (RdRp), the largest protein produced by 
hantavirus (~250-280kDa), is the key polymerase for transcription and replication 
of the hantavirus genome. In order to perform both of the above functions, RdRp 
must have multiple enzymatic activities in addition to transcriptase and replicase. 
The additional activities may include a RNA endonuclease and possibly a RNA 
helicase activity. However, it is commonly known that RdRp lacks enzymatic 
activity necessary for capping and proof-reading. [48-50] It was long suggested 
from a study in bunyamwera virus that the L protein has the endonuclease 
 7 
activity[51]. The structural and mutational studies using La Crosse (LACV, 
Bunyaviridae, genus Orthobunyavirus) RdRp revealed an endonuclease domain 
at its N-terminus that is similar to the endonuclease domain resides within PA 
subunit of the influenza polymerase [52]. In addition to the endonuclease domain, 
RdRp has a core structural polymerase domain that is conserved between both 
positive and negative strand RNA viruses. The overall structure of the core 
domain, which forms a right-handed fold, can be divided into three subdomains: 
thumb, the finger, and the palm [53, 54]. Sequence comparison revealed four 
highly conserved motifs (motif A-D) within the palm subdomain [54, 55]. The core 
residues essential for catalytic activity of polymerase resides within motif C, 
mutation of those residues results in loss of viral RNA synthesis in bunyamwera 
virus [56-58]. 
In addition, hantavirus RdRp is thought to be associated with the RNPs so 
that it is ready to initiate viral RNA synthesis immediately after the virus entry into 
host cell [59]. To date, there is no direct evidence for this model except that it 
was observed that hantavirus L protein, at least partially, is colocalized with the N 
protein in the Golgi region [60]. 
 
Non-structural proteins, NSS 
In some hantaviruses, S segment also encodes a small non-structural 
protein from an overlapping reading frame, which possibly functions in interferon 















Figure 1 Hantavirus particle and genomic organization. 
(A) A schematic diagram of hantavirus particle showing RNP organization. 
(Modified from Vaheri et al 2013, ref 195) (B) Hantavirus particle under an 
electron microscope (image from CDC website) (C) Gene segments and protein 
expressed from each segments in hantaviruses.   
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2. Cap snatching, a unique transcription initiation mechanism of negative 
strand RNA viruses 
 
The 5' cap structure (m7G) is an essential feature of eukaryotic mRNA 
required for mRNA stability and efficient translation. Viruses that infect eukaryotic 
cells rely heavily on the host cell machinery for translation. Thus, while some 
viruses, such as HCV, do not require capped mRNA to initiate translation, most 
viruses have to cap their mRNAs.  
Some viruses cap their mRNA through capping enzyme, encoded either 
by host (DNA viruses) or virus itself (e.g. Dengue virus, vaccinia virus). However, 
some negative strand RNA viruses from Orthomyxoviridae, Bunyaviridae and 
Arenaviridae, which do not encode capping enzymes, have evolved a unique 
mechanism for transcription initiation called cap snatching. Cap-snatching was 
first described in influenza virus (Orthomyxoviridae) [62]. This process involves 
processing of host mRNA (in case of influenza, pre-mRNA) into short capped 
oligos and using them as primers for mRNA synthesis.  
Cap-snatching mechanism has been extensively studied in influenza virus. 
In vitro and in vivo studies using either purified RNP or viruses revealed a 
preference on capped RNA primers based on sequence complementary to the 3’ 
end of vRNA template [63]. 
 
In addition, in vivo studies in infected Madin-Darby canine kindey (MDCK) 
cells also found internal priming at the 3’-penultimate residue, suggesting a 
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“prime-and-realign” mechanism for influenza virus cap-snatching. The 
heterotrimeric polymerase consists of PA, PB1 and PB2 subunit thought to be 
the key player for influenza cap-snatching. PB2 subunit binds the 5’ cap of host 
pre-mRNAs [64-66], which are subsequently cleaved after 10–13 nucleotides by 
the viral endonuclease, resides within N-terminus of PA subunit [67]. Further in 
vitro study using purified PA N-terminal (PA-Nter) fragment showed that the 
endonuclease domain within the PA subunit recognizes a 5’- CG-3’ motif from a 
20-mer single strand RNA substrate for cleavage and changes on either the 
order or the composition of nucleotides in the 20-mer results in inefficient 
cleavage [68]. However, endonuclease activity of the PA-Nter is not affected by 
the presence of the cap at the 5’ end of the RNA substrate. However, when the 
same RNA substrate is incubated with the purified viral RNP, the cleavage 
efficiency is strongly increased in the presence of 5’ cap on the RNA substrate, 
whereas the recognition motif for cleavage is the same. Furthermore, analysis of 
the cleavage product showed that when guanine is present within 10-13 nt from 
the cap, RNP exhibits a dominating preference for it; whereas in the absence of 
guanine, RNAs are cleaved with high selectivity at the 12th nucleotide 
downstream from the cap. Thus, the combination of these studies suggest that 
although PA Nter endonuclease exhibits preference on G residue, the overall 
endonuclease specificity of RNP on a cap-donor is also determined by a 
combination of cap-binding-mediated distance measurement from the 5’ end of 
the RNA [68]. 
In the case of hantaviruses, evidence supporting prime and realign 
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mechanism has also been observed from sequencing data [69]. It is suggested 
that first C of the AUC repeats at the vRNA 3’ terminus pairs with 3’ G residue 
from the capped oligos derived from host mRNA; after successive addition of 
bases, the nascent RNA slips back a few bases and realigns with the 
complementary nucleotides at the 3ʹ end of the vRNA [69]. Host mRNAs are 
processed for viral use at the replication site by the endonuclease activity of 
RdRp, thus producing capped primers of 10–15 bases for the transcription of 
viral mRNAs [52, 70]. 
In addition, the endonuclease activity similar to that of influenza virus PA 
subunit has also been demonstrated in LACV [52]. The amino acid motifs 
responsible for endonuclease activity are located at the N-terminus of the RdRp, 
and can be inhibited by an endonuclease inhibitor that specifically antagonizes 
the activity of PA.  
However, unlike influenza virus, which replicates inside the nucleus and 
snatches caps from pre-mRNA, the hantaviruses entire life cycle is in the 
cytoplasm where only the cytoplasmic mRNAs are accessible for use as capped 
primers. It is not fully understood how cytoplasmic mRNAs are utilized by 
hantaviruses as primers, however, it has been suggested that acquisition of 
capped mRNA as primer by hantaviruses may involve the localization of viral 
proteins to cytoplasmic processing bodies (P-bodies), where they can access 
host mRNAs that are sequestered and possibly destined for degradation. The 
supporting evidence is that hantavirus N protein co-localizes with the P-body 
formed at the perinuclear region and during viral infection the stability of RNAs 
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targeted for degradation increase [37]. After N protein associates with the capped 
mRNA in the P-body, they are either been transported to the ER–Golgi 
intermediate compartment, a putative site for viral replication [71], or initiate viral 
















Studies in the past have revealed that when the mRNA is no longer active 
in translation and targeted for sequestration or degradation, translationally 
repressed messenger ribonucleoproteins (mRNPs) form from the mRNA and 
associate with the cytoplasmic decapping machinery to form aggregated 
granules [72, 73]. These aggregates are named P-bodies (processing bodies or 
GW bodies).  
3.1 P-body structure, formation and mRNA fate 
Although complete protein composition of P bodies is unknown; P-body 
components identified to date can be roughly divided into three classes: First 
class includes proteins from mRNA decapping machinery, such as the decapping 
enzymes Dcp1, Dcp2, decapping activators Dhh1, Edc3, Lsm1-7, as well as the 
5’ to 3’ exonuclease and the deadenylase CCR4/NOT [74-76]. These 
components form the core of the P-body and are conserved from yeast to 
mammals and are mostly members of the mRNA decay machinery. The second 
class of P-body components is more dynamic; the association of them with the 
core components depends on the organism of specific subset of mRNAs. For 
example, proteins involved in nonsense-mediated decay (NMD), which are not 
permanent components of the P-body, and are only found in P-bodies under 
certain conditions such as stress [77, 78]. 
The last component is the mRNA. [79, 80] It has been demonstrated that 
mRNA is required for the formation of the P-body, as RNase treatment in vitro 
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disrupted P-bodies purified from the cells [79].  
Overexpression of a non-translating mRNA yeast also suggested P-body 
size and number are correlated to the amount of mRNA that is not participating in 
translation [79]. It is also suggested that mRNAs associated with P-bodies are 
not engaged in translation. Treatment of cells with cycloheximide that entraps 
ribosomes on the mRNA and depletes ribosome free mRNAs, results in the 
disappearance of visible P-bodies [73, 74, 79]. Conversely, the size of P-bodies 
increases when mRNAs dissociate from ribosomes [79, 81, 82]. Thus, one would 
speculate that translation initiation factors and ribosomes are absent in P-bodies 
and their associated mRNAs [75, 79, 83, 84]. However, one exception is eIF4E, 
the cap-binding subunit of the eIF4F initiation complex, although the capped 
mRNA in associated in P-bodies are translationally repressed [75, 84, 85].  
The kinetic model of P-body formation is still unclear. Several lines of 
evidence suggest mRNPs must be translationally repressed and recruit 
cytoplasmic factors to form a P-body [72, 78, 79, 86-88]. It has been suggested 
that decapping accessory proteins Dhh1 and Pat1, serve as first activators of P-
body formation followed by translation repression [86, 89-94]. Yeast strains 
lacking Dhh1 and Pat1 display defects in translational repression as well as P-
body formation under stress while overexpression of Dhh1 and Pat1 promotes 
the formation of visible P-bodies [86]. However, although translational repression 
is clearly required for the assembly of an mRNP into a P-body, it may not be 
sufficient. In addition, Edc3 and Lsm4 were identified as factors required for P-
body assembly from a yeast study, since deletion of both Edc3 and Lsm4 leads 
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to a complete failure of P-body formation without any effect on mRNA decay [87, 
95]. In addition, single deletion of each factor did not affect P-body assembly, 
suggesting Edc3 and Lsm4 might involve in two separate complexes through 
interacting with different proteins, in this case, Dhh1 and Pat1, respectively, may 
independently promote P-body formation [87, 90, 93]. In mammalian cells, while 
Edc3 is highly conserved in the interaction domain [96], Lsm4 might be 
functionally replaced by Hedls or GW182 that contains predicted Q/N-rich motif 
similar to yeast Lsm4 [87, 95]. Knockout studies also confirmed the importance of 
the two proteins in promoting P-body assembly. [72, 97-99] 
Once associated with the P-body, mRNAs may go into two fates: Firstly 
decapping/degradation and secondly return to translation. Three lines of 
evidence support decapping/degradation. First, many mRNA decapping factors 
are found concentrated in P-bodies. Second, mRNA decay intermediate is 
localized to P bodies followed by a stall or inhibition of decay [73]. Third, P-
bodies change in size when mRNA decay pathway is perturbed [73-75, 86, 100]. 
Many observations demonstrated that specific mRNAs accumulated in P bodies 
under certain conditions re-associate with polysome when conditions alter [83, 
101]. These evidences suggest instead of solely being a factory of mRNA decay, 
P-bodies serve as a point of mRNA turnover cycle where sequestered mRNAs 
are stored for either decay or translation depending on the environment. Thus P-
bodies are highly dynamic structures with different flexible components that 
associate and dissociate at different rates, but in a regulated fashion, possibly 
depending on the fate of the specific mRNAs [75, 82]. 
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3.2 P-body and Viruses 
It is well known that viruses do not encode their own translation or even 
transcription machinery due to their coding capacity. Thus one important aspect 
of host-viral interaction is how virus interacts with host machinery for translation, 
transportation and degradation of mRNAs. Many studies have found components 
of P-bodies are important for the successful life cycle of some retro viruses and 
other RNA viruses, moreover, some viral proteins has been observed to 
accumulate within the P-bodies. This suggests that P-bodies may play important 
role in the virus life cycle. 
With HIV, the P-body component DDX3 was found to be required for 
unspliced genomic RNA export from the nucleus, and targeting the unspliced 
mRNA to the P-bodies was thought to be important for packaging [102]. With the 
plant virus brome mosaic virus (BMV, (+) ssRNA virus), P-bodies have been 
suggested to be important for initiating genome replication, as many viral 
proteins, including RNA1-3, RdRp are found within the P-bodies [103]. In 
addition, P-bodies were also shown to associate with the membrane-bound BMV 
replication complex [104]. Similarly, P-bodies were observed to increase hepatitis 
C virus (HCV) by targeting the viral genome to the P-body by binding to a liver 
specific miRNA, miR-122 [80, 105]. 
Interestingly, viral proteins from negative-stranded RNA viruses also 
interact with the P-body. The influenza virus NS1 was found to interact with P-
body through a core component RAP55 (Lsm14A). It was suggested that NS1 
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interacts and disrupts RAP55 associated P-bodies to release NP associated 
mRNAs that are targeted to P-bodies, thus restoring viral translation [106]. In 
hantaviruses (Bunyaviridae family) infected cells, N proteins are found to be 
associated with the P-bodies, and expression of the N proteins inside the cell 
increases the steady state level of the mRNA containing a pre-mature 
termination codon (PTC), a mutated stop codon in the middle of a ORF, which 
are targeted to degradation [37]. This observation suggested that N protein 
protects the 5’ terminus of the capped mRNA sequestered within the P-body. N 
was speculated to remain bound to the caps during transcription and serve in 
translation initiation immediately following viral mRNA synthesis. Two lines of 
evidence supported the speculation:  first, N is able to initiate translation by 
binding to the 5’ cap and functionally replaces eIF4F [31]; this was in consistent 
with the observation that the host cap-binding protein within the translation 
initiation complex, eIF4E is also found to be associated with the P-body.[84] 
Second, bunyaviridae mRNA translation is coupled with transcription [107]. In 
conclusion, P-bodies play an important role in viral replication, and virus interacts 
with P-body to regulate host functions such as mRNA decay and translation to 






4. mRNA decay, decapping and viruses 
In eukaryotes, mRNA decay mechanisms are evolved not only to serve as 
quality control to prevent production of malfunction or toxic proteins, but also as a 
way of protein regulation through altering mRNA half-life. The general 
mechanism of eukaryotic mRNA degradation can be divided into three types: 
deadenylation dependent 3’ to 5’ decay, endonucleolytic digestion, and specific 
quality control pathways [108]. RNA decay mechanisms, depending on the 
purpose, are regulated through distinct pathways. Current studies only revealed 
a small fraction of the network of pathways actually exist in the cell. The 
regulated RNA decay mechanism that has been described include nonsense-
mediated mRNA decay (NMD), that mainly responsible for quality control of 
newly synthesized mRNAs; histone mRNA decay that exemplify a cell-cycle-
regulated process and AU-rich element (ARE)-mediated mRNA decay, which is 
induced by destabilization elements in the 3’ untranslated region (UTR) [108]. 
Due to the relevance of the dissertation, only NMD is discussed here.  
4.1 Non-sense mediated mRNA decay (NMD) 
Nonsense-mediated mRNA decay (NMD) exists in all eukaryotes to 
eliminate mRNAs that has pre-mature termination [109]. NMD is essential as a 
surveillance pathway to prevent translation of aberrant protein and accumulation 
of non-translation mRNAs [110]. This mechanism is translation coupled and 
prevents the potentially toxic effects of defective transcripts that are routinely 
generated during gene expression [111]. 
NMD is thought to target mainly newly synthesized mRNAs during the very first 
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round of translation. The newly synthesized mRNA normally has exon-junction 
complexes (EJCs) bound to their exon junction, and would be removed by 
ribosome during the first round of translation [111]. When mRNA contains a PTC 
before the exon junction, the EJC will remain bound to the mRNA when 
ribosomes fall off from the mRNA before removing the EJC, NMD is then 
activated [108]. Three conserved factors are critical for NMD: UPF1, UPF2 and 
UPF3 [112-114]. In mammals, PTC-induced NMD is initiated by interaction 
between cap-binding protein CBP80 and UPF1, the interaction complex in turn 
recruits SMG1 and contact with UPF2 and UPF3 within the EJC, triggering the 
phosphorylation of UPF1. The phosphorylated UPF1 then recruits SMG-5, SMG-
6 and SMG-7, which mediates a series of mRNA degradation events including 
decapping, 5’ to 3’ decay and 3’ to 5’ decay [112, 115, 116]. 
In addition, recent studies revealed that NMD might also initiate 
independent of EJC or splicing [117, 118]. For example, immunoglobulin-ì mRNA 
is subjected to EJC-independent NMD even when PTC is located at the 
penultimate exon. The activation of this type of NMD depends on the length of 3’ 
UTR.[117] Moreover, a study on Rous Sarcoma virus RNA found that unspliced 
viral RNAs, when inserted with a PTC, became substrates for the NMD pathway. 
This splicing independent NMD also requires UPF1 [119]. Furthermore, non-
coding RNAs (ncRNA) can also be targets of NMD. The growth arrest-specific 5 
(GAS5) ncRNA accumulates during growth arrest induced by serum starvation. A 
study showed that the ncRNA, GAS5, could be degraded specifically by NMD, as 
siRNA knockdown of UPF1 significantly increases the stability of GAS5 RNA 
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[120]. It has been proposed that P-bodies (described in earlier section) are the 
site where NMD is executed. In support of the concept, core NMD factors UPF1, 
UPF2 and UPF3 have been found associate with P-bodies [121]. It has also been 
proposed that UPF1 directs PTC-containing mRNAs to P-bodies and triggers 
decay [122]. 
4.2 Decapping and the impact on Bunyaviridae family viruses 
When mRNA is targeted for degradation in either 5’ -3’ and 3’-5’ fashion, 
decapping is always required. Three decapping enzymes has been shown to 
involved directly in the decapping process, Dcp2, Nudt16 and DcpS. Dcp2 and 
NUDT16 belong to the Nudix (nucleoside diphosphate linked moiety X) 
phosphatidyl hydrolase family, which catalyzes mRNA cap hydrolysis in the 5’-3’ 
mRNA decay pathway in a metal-dependent reaction that releases m7GDP and 
monophosphate-terminated mRNA. 
Dcp2 is the first identified decapping enzyme, which is highly conserved in 
eukaryotes. The decapping activity resides in the central domain consisting of a 
Nudix fold structure. Dcp2 was reported to hydrolyze monomethylated, 
trimethylated and unmethylated capped RNA with different efficiencies in vitro. 
Dcp2 only cleaves capped RNA with longer than 25nt, it binds to the RNA and 
cleaves only cap structure. Dcp2 forms a complex with Dcp1 in vivo, and the in 
vivo activity of Dcp2 is critically dependent on Dcp1. Point mutations on Dcp1 
without interfering Dcp1:Dcp2 association disrupt the decapping activity of 
Dcp1:Dcp2 complex in vivo [123, 124]. Nudt16 is another Nudtix motif containing 
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enzyme that has been demonstrated with decapping activity in vitro and in the 
cytoplasm of mammalian cells.[125] 
In contrast, DcpS in contrast is a scavenger decapping enzyme that 
belongs to HIT protein family that catalyze residual cap-mRNA hydrolysis in an 
exosome mediated 3’ to 5’ decay pathway [126]. In both yeast and mammalian 
cells, decapping by Dcp1:Dcp2 complex has been demonstrated to be stimulated 
by interacting with several proteins, including Dhh1, Lsm proteins, Pat1, and 
enhancer of decapping (Edc) proteins. In yeast, Dhh1, Lsm 1-7 and Pat1 are 
found associated with the Dcp1:Dcp2 complex [91, 93, 94]. Depletion of any of 
these factors in S. cerevisiae results in accumulation of capped, deadenylated 
mRNAs, which suggests that they are critical for deadenylation-mediated 
decapping. Dhh1 is speculated to present the 5’ end of the mRNA to decapping 
enzymes and Lsm 1–7 proteins were suggested to possibly recruit the decapping 
complex to deadenylated mRNAs [91, 92]. It is noteworthy that Dhh1 and Lsm1-7 
are essential for initiating the formation of P-bodies. Decapping by Dcp1:Dcp2 
complex plays a key role in NMD pathway,  siRNA knockdown of Dcp2 results in 
impaired NMD in vivo.  Although the mechanism of how NMD activates 
decapping is not understood, it has been shown that the core NMD protein, 
UPF1 is associated with the Dcp1:Dcp2 complex [127, 128]. 
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5. Summary and Objectives 
 
Hantaviruses have evolved a sophisticated strategy to initiate transcription 
in order to produce capped mRNAs. Although viral N protein has been shown to 
specifically enhance viral translation by recognizing the 5’ triplet UAG repeats on 
the viral mRNA, efficient translation of viral transcripts in the absence of a cap 
structure has not been demonstrated. Thus the virus needs to acquire cap from 
the host mRNA (cap-donor) to not only achieve efficient translation, but also 
mRNA stability. It has been demonstrated that in influenza virus, non-viral lead 
sequence at the 5’ of the viral mRNA mostly ends with GC or AGC, suggesting 
influenza virus prefers leader sequences with base complementarity to the most 
3’ nucleotide of the vRNA. The degree of complimentary to the 3’ vRNA also 
determines the preference of specific cap-donor to be used as the primer [63]. In 
addition, cap-donor length is found to be 10 or 11 nt [63]. This is in consistent 
with the later in vitro study using purified endonuclease domain from PA (PA-
Nter) to digest RNA substrates. PA-Nter recognize and digest RNA substrate at 
the 5’-CG-3’ motif [68]. 
Similar observation has been found in bunyaviridae that the virus prefers 
to have the capped primer 10-20 nucleotides. Thus, it is of interest to determine 
whether hantavirus, a member of bunyaviridae, shows similar preference of cap-
donor mRNA base on the complimentary between the nucleotides on the cap-
donor and the vRNA. 
Unlike influenza virus, hantavirus only replicate in the cytoplasm. Thus, 
the pool of the potential cap donors is only limited to the cytoplasmic mRNA. It is 
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important to find how hantavirus manages to snatch caps efficiently from the 
cytoplasmic mRNAs, since they are often engaged with the translation 
machinery. The observation that N protein co-localizes with the P-bodies and 
protects mRNA from decay leads to the speculation that hantavirus may acquire 
cap from a specific population of cytoplasmic mRNAs, which are sequestered 
and designated for degradation.  
 
In addition, the study that characterizes the endonuclease activity of 
influenza polymerase subunit PA observed differences of endonuclease 
specificity between the purified PA endonuclease domain PA-Nter and the viral 
RNP. The study demonstrated the importance of the 5’ cap to the endonuclease 
within the vRNP. Both potency and specificity increases when a 5’ cap is added 
to the endonuclease substrate. The results suggested a difference in the RNA 
cleavage site choice might be guided by cap binding to the PB2 subunit [68]. In 
hantaviruses, the RdRp is expressed as a single protein. Although similar 
endonuclease activity has been observed from the N-terminal fragment of the 
RdRp, the activity suggested being non-specific. Moreover, the cap binding of 
RdRp has not been demonstrated, and the cap-binding motif has not been 
observed within RdRp [52]. Thus, further studies are required to demonstrate 
how hantavirus RdRp can also achieve specific cleavage of the mRNA substrate; 
and whether the specificity is induced by its cap binding, or cap binding ability or 





Signatures of Host mRNA 5’ Terminus for Efficient Hantavirus 
Cap Snatching 
Abstract 
Hantaviruses, similarly to other negative-strand segmented RNA viruses, 
initiate the synthesis of translation-competent capped mRNAs by a unique cap-
snatching mechanism. Hantavirus nucleocapsid protein (N) binds to host mRNA 
caps and requires four nucleotides adjacent to the 5’ cap for high-affinity binding. 
N protects the 5’ caps of cellular transcripts from degradation by the cellular 
decapping machinery. The rescued 5’ capped mRNA fragments are stored in 
cellular P bodies by N, which are later efficiently used as primers by the 
hantaviral RNA-dependent RNA polymerase (RdRp) for transcription initiation. 
We showed that N also protects the host mRNA caps in P-body-deficient cells. 
However, the rescued caps were not effectively used by the hantavirus RdRp 
during transcription initiation, suggesting that caps stored in cellular P bodies by 
N are preferred for cap snatching. We examined the characteristics of the 5’ 
terminus of a capped test mRNA to delineate the minimum requirements for a 
capped transcript to serve as an efficient cap donor during hantavirus cap 
snatching. We showed that hantavirus RdRp preferentially snatches caps from 
the nonsense mRNAs compared to mRNAs engaged in translation. Hantavirus 
RdRp preferentially cleaves the cap donor mRNA at a G residue located 14 
nucleotides downstream of the 5’ cap. The sequence complementarity between 
the 3’ terminus of viral genomic RNA and the nucleotides located in the vicinity of 
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the cleavage site of the cap donor mRNA favors cap snatching. Our results show 
that hantavirus RdRp snatches caps from viral mRNAs. However, the negligible 
cap-donating efficiency of wild-type mRNAs in comparison to nonsense mRNAs 
suggests that viral mRNAs will not be efficiently used for cap snatching during 
viral infection due to their continuous engagement in protein synthesis. Our 
results suggest that efficiency of an mRNA to donate caps for viral mRNA 



















Hantaviruses, members of the Bunyaviridae family, are transmitted to humans 
through aerosolized excreta of infected rodent hosts. Their infection causes 
hantavirus cardiopulmonary syndrome (HCP) and hemorrhagic fever with renal 
syndrome (HFRS)[129, 130], with mortalities of 50% and 15%, respectively. The 
spherical hantavirus particles harbor three negative-sense genomic RNA 
segments, S, M, and L, within a lipid bilayer[131]. The mRNAs derived from S, L, 
and M segments encode viral nucleocapsid protein (N), RNA-dependent RNA 
polymerase (RdRp), and glycoprotein precursor (GPC), respectively. The GPC 
precursor is cleaved into two glycoproteins, Gn and Gc. The characteristic 
feature of the hantaviral genome is the partially complementary sequence at the 
5’ and 3’ termini of each of the three genome segments that undergo base 
pairing and form panhandle structures[132-134]. N is a multifunctional protein 
playing a vital role in multiple processes of the virus replication cycle and has 
been found to undergo trimerization both in vivo and in vitro [29, 31, 36, 135-
143]. N specifically encapsidates the three viral genomic RNAs into 
nucleocapsids which are packaged into virions. 
The sequence of L segment RNA has been determined for about 20 viruses in 
the Bunyaviridae family, including nine hantaviruses. Except for the tospovirus 
and nairovirus, the RdRps of all other bunyaviruses are of a similar molecular 
mass (∼250 kDa). The requirement of both RdRp and N for 
replication/transcription of the viral genome has been demonstrated for both 
hantaviruses and other bunyaviruses [137, 144-146]. Using a green fluorescent 
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protein (GFP) fusion protein, the localization of Tula hantavirus RdRp has been 
found to be perinuclear. The punctate expression pattern of the L-enhanced GFP 
(EGFP) fusion protein has led to the suggestion that RdRp is membrane 
associated [60, 64]. The 5’ and 3’ termini of the hantaviral genome contain 
untranslated regions (UTRs) of various lengths. Assays in which reporter genes 
have been flanked by these UTRs have shown that promoters for viral RdRp are 
located in these critical UTR sequences. In the Orthobunyavirus Bunyamwera, 
base pairing of 5’ and 3’ termini of the viral genomic RNA was found to be 
required for the synthesis of RNA by viral RdRp [147]. Studies on the 
characterization of the influenza A virus promoter have suggested a corkscrew-
like secondary structure formed by the base pairing of partially complementary 5’ 
and 3’ ends of the viral genome [148]. 
The RdRp from segmented negative-sense RNA viruses requires a capped RNA 
primer to initiate the transcription [149-153]. The capped RNA primer is 
generated from the 5’ terminus of host cell mRNA by the “cap-snatching” 
mechanism, which has been well characterized for the influenza virus [62, 66, 
154-156]. Although the knowledge about the sequence, length, and structure of 
the 5’ mRNA terminus that donates the primer is rather limited, most common 
cap donor mRNAs are cleaved 15 nucleotides downstream of the cap, with a 
variation of 10 to 20 nucleotides [133, 150, 151, 154, 157-161]. The use of 
capped primers following a “prime and realign” mechanism has been suggested 
for the Bunyaviridae transcription initiation [69]. Transcription termination signals 
have been identified in Hantaan and Sin Nombre virus (SNV) mRNAs. SNV S 
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and L segment mRNAs are not polyadenylated; however, M segment-derived 
mRNA is polyadenylated and synthesis is terminated at a (U)8 polyadenylation 
transcription termination signal [162]. 
A cap-snatching mechanism similar to that in influenza virus has been proposed 
for all minus-strand segmented RNA viruses, including the bunyaviruses and 
arenaviruses, although their RdRps are structurally different and they replicate at 
different locations inside the host cell. Unlike the situation in influenza virus, the 
RdRp of bunyaviruses and arenaviruses is encoded by one rather than three 
genes. Recent studies have suggested that RdRp from bunyaviruses and 
arenaviruses harbors the endonuclease domain at the N terminus, and its 
endonuclease activity has been demonstrated [163]. Moreover, influenza viruses 
carry out cap snatching and transcription in the nucleus of infected cells, whereas 
bunyavirus and arenavirus transcription and genome replication are cytoplasmic. 
Unlike influenza virus, the viruses carrying out cap snatching in the cytoplasm 
have to compete with the cellular RNA degradation machinery, which actively 
removes caps and degrades cellular transcripts after the completion of 
translation. 
The eukaryotic mRNA degradation machinery follows two general decay 
pathways, both of which begin with the shortening of the 3’ poly(A) tail by a 
process known as deadenylation [164]. Following deadenylation, mRNAs can be 
degraded by a 3’-to-5’ exosome under the control of peptides of the SKI complex. 
Alternatively, after deadenylation, mRNAs can be decapped by the Dcp1/Dcp2 
decapping enzymes, followed by 5’-to-3’ degradation by exonuclease XRN1 [77, 
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165, 166]. Decapping and XRN1-dependent 5’-to-3’ decay form the predominant 
pathway for the degradation of cellular mRNAs. Moreover, the components of 
this pathway, including decapping enzymes Dcp1/Dcp2, exonuclease XRN1, and 
other peptides that function in mRNA degradation and regulation, are located in 
discrete cytoplasmic foci termed processing bodies (P bodies) [77, 165, 166]. 
In addition to these two mRNA degradation pathways, eukaryotic cells also use 
elegant mRNA surveillance or quality control mechanisms to ensure the 
translation of error-free mRNAs. Among these, the most prevalent and well-
characterized mechanism is the nonsense-mediated mRNA decay (NMD) 
pathway, which recognizes and degrades mRNAs containing premature 
translation termination codons (PTCs) [167]. Premature translation termination 
leads to the assembly of the surveillance complex on mRNA, which triggers 
NMD. The surveillance complex is composed of the UPF1 to three proteins and 
four additional NMD effectors (SMG1 and SMG5 to 7) [168-170]. Assembly of the 
surveillance complex recruits the decapping enzymes and XRN1, but it can also 
accelerate the deadenylation and 3’-to-5’ degradation by the exosome and the 
SKI complex [171, 172]. The enzymes that function in general mRNA decay also 
function in NMD, and the mRNA molecules containing PTCs are targeted to P 
bodies for rapid decay [168-170]. 
We have recently found that SNV N protein resides in cellular P bodies and also 
binds specifically to the mRNA 5’ caps [32, 36, 37]. This specific interaction 
prevented the 5’ caps of cellular mRNAs from degradation by the cellular 
decapping machinery. The rescued 5’-capped oligoribonucleotides were stored in 
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P bodies by N and were later used as primers by the hantavirus RdRp [37]. We 
reported that 5’-capped mRNA oligonucleotides sequestered in P bodies by N 
were at least 180 nucleotides in length [37]. The mechanism generating the 
shorter primers of appropriate length and specificity is still unknown. In this 
paper, we examine the characteristics of the 5’ terminus of a capped test mRNA 
to delineate the minimum requirements for a capped transcript to serve as an 
efficient cap donor during cap-snatching mechanism of transcription initiation by 

















2. Materials and Methods 
Oligonucleotides, enzymes, and other reagents. PCR primers were from 
Integrated DNA technologies. All restriction enzymes were from New England 
BioLabs. Platinum PCR Supermix was from Invitrogen. Phusion high-fidelity DNA 
polymerase was from NEB. RNA purification reagents were from Qiagen, and 
reverse transcription reagents were from Invitrogen. Power SYBR green PCR 
master mix was from Applied Biosystems. TA cloning reagents were from 
Invitrogen. All other chemicals were purchased from Sigma. The reagents for 5′ 
rapid amplification of cDNA ends (RACE) were purchased from Roche Applied 
Science. 
Constructs. The plasmid pCDNAGFP expressing green fluorescent protein 
(GFP) was PCR amplified from plasmid pEGFP-C1 (Clontech) using a forward 
primer, 5′-GATTATGCTAGCATGGGGTCTCATGGCGAGGA-3′, and a reverse 
primer, 5′-GTATTCTCGAGTTATCTAGATCCGGTGGATCCC-3′ (boldface and 
italics indicate restriction sites). The PCR product was gel purified, digested with 
NheI and XhoI restriction enzymes, and cloned between the same restriction 
sites in pCDNA3.1+ vector (Invitrogen). The plasmid pCDNAGFPns, which does 
not express GFP due to two substitution mutations, was cloned in pCDNA3.1+ 
using the forward primer 5’-GATTATGCTAGCATGGGGTGATCATGGCGAGGA-
3′ and the reverse primer described above. The plasmid pCDNAGFPnsG0, 
expressing a GFP mRNA harboring five substitution mutations at the 5′ 
untranslated region (UTR) of mRNA, was constructed by generating a PCR 
product from pCDNAGFPns plasmid using forward primer F1, 5’ –
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AGTGTATCATATGCCAAGTAC-3’, and reverse primer R1, 5′-
GGATAAGGGAGTAAGGAGTGGGTTGTGTA-3’. Similarly, another PCR product 
was generated from pCDNAGFPns plasmid using forward primer F2, 5′-
TACACAACCCACTCCTTACTCCCTTATCC-3′, and reverse primer R2, 5′-
TCTAGACTCGAGTTACTTGTACAGCT-3′. The two PCR products were gel 
purified and mixed together. The mixture was used as the template and a third 
PCR product was generated using forward primer F1 and reverse primer R2. 
This final PCR product was again gel purified, digested with NdeI and XhoI, and 
cloned between the same restriction sites in pCDNA3.1+ backbone. Using this 
cloning strategy, the mutations were incorporated through forward primer F2 and 
reverse primer R1. The same strategy was used for the construction of other 
plasmids (see Fig. 9A and Fig. 10A). In all these constructs the same forward F1 
and reverse R2 primers were used. However, the sequences of reverse R1 and 
forward F2 primers were different, depending upon the type of mutation (Table 
1). 
Reverse transcription and real-time PCR. Vero E6 cells in six-well plates were 
transfected with the plasmid of interest, using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer's instructions. Eight hours posttransfection, cells 
were infected with Sin Nombre virus (strain 77734, a gift from Brian Hjelle, 
University of New Mexico) at a multiplicity of infection (MOI) of 1.0. Cells were 
lysed 48 h postinfection, and total RNA was purified using the RNeasy kit 
(Qiagen), including treatment with RNase-free DNase I (Qiagen), following the 
manufacturer's protocol. Two micrograms of total RNA from each well was 
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reverse transcribed using Moloney murine leukemia virus (M-MLV) reverse 
transcriptase (Invitrogen) and a primer specific to the viral S-segment mRNA (5′-
ACTAAAGCCAATCACACCCATGACA-3′) in a total volume of 20 µl. Two 
microliters of the resulting cDNA was used in 20-µl real-time PCRs. The relative 
quantification method was used for real-time PCR using an ABI Prism 7700 
sequence detection system following the manufacturer's instructions (Applied 
Biosystems). Fold change in mRNA levels and standard deviation were 
calculated by the relative quantification method, which is described in detail in the 
ABI instruction manual 
(http://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/gener
aldocuments/cms_040980.pdf). We used a universal primer set with a forward 
primer (5′-TGGCTAACTACACAACCC-3′) and a reverse primer (5′-
ATGGTCATCAGGTTCAATCC-3’) to amplify 290 nucleotides from the 5′ 
terminus of viral S-segment mRNA. This universal primer set was used in all real-
time PCRs reported in this paper, unless otherwise stated. The forward primer is 
complementary to the 5′ terminus of GFP mRNA, which is expressed from the 
transfected plasmid, and the reverse primer is complementary to the open 
reading frame of viral S-segment mRNA. This primer set will generate products 
only if the viral S-segment mRNA has snatched a cap from the GFP mRNA 
(discussed in more detail in Results). Amplification of β-actin mRNA as an 
“internal control” was carried out using a forward primer, 5′-
CCATCATGAAGTGTGACGTGG-3’, and a reverse primer, 5′-
GTCCGCCTAGAAGCATTTGCG-3’, as previously reported[37]. To ensure the 
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amplicon specificity of each primer set, the PCR products were subjected to 
melting curve analysis followed by sequential agarose gel electrophoresis. The 
efficiency for amplification of the target (5′ terminus of the viral S-segment 
mRNA) and the internal control gene (β-actin) was examined using serial 
dilutions of cDNA. The mean difference between threshold cycle number values 
was calculated for each cDNA dilution. The mean difference values 
corresponding to each dilution were plotted and fit to a straight line with a slope 
of <0.1. After this validation test, the levels of S-segment mRNA which have 
snatched caps from the test mRNA expressed from the transfected plasmid in 
Vero E6 cells were calculated following normalization to the β-actin mRNA levels 
and expressed as relative units. Intrinsic steady-state levels of GFP reporter 
mRNA in transfected cells were monitored by real-time PCR analysis using a 
forward primer, 5′-CACATGAAGCAGCACGACTT-3′, and a reverse primer, 5′-
AGTTCACCTTGATGCCGTTC-3′. This primer set is specific to the GFP open 
reading frame. 
TA cloning. During cap snatching, hantaviruses typically cleave the host cell 
mRNA at a G residue located 8 to 17 nucleotides downstream of the terminal cap 
[69]. To determine whether the caps derived from the mRNAs expressed from 
transfected plasmids (pCDNAGFP/pCDNAGFPns) exhibit these hallmarks of 
correct cap snatching, we sequenced the cap-viral UTR junctions of viral S-
segment mRNAs, which have obtained their caps from either GFP mRNA or 
nonsense GFP mRNA. Vero E6 cells were transfected with either plasmid 
pCDNAGFP or plasmid pCDNAGFPns, followed by viral infection 4 h 
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posttransfection. Cells were lysed 48 h postinfection, and total RNA was purified 
and reverse transcribed using a primer specific to the S-segment mRNA, as 
described above. The cDNA was PCR amplified using a primer set shown in Fig. 
2A. The PCR product was cloned using a TA cloning kit (Invitrogen) by following 
the manufacturer's instructions. Plasmid DNA was purified from 20 randomly 
selected clones and sequenced in the region corresponding to the cap-UTR 
junction, as previously reported[37].  
siRNA knockdown. To substantiate the role of P bodies in hantavirus cap 
snatching, two essential P-body components, GW-182 and Ge-1, were 
downregulated by small interfering RNA (siRNA) transfection. The GW-182, Ge-
1, and control siRNAs were purchased from IDT. The sequences for the GW-182 
siRNAs were 5′-GGAAUGUUACAAGACAAACGAAUGG and 5′-
CCAUUCGUUUGUCUUGUAACAUUCCUA-3′. The sequences of the Ge-1 
siRNAs were 5′-GGAUGUUAGCCAGAUCAAGCAGGGC-3′ and 5′-
GCCCUGCUUGAUCUGGCUAACAUCCAC-3′. Both GW-182 and Ge-1 siRNAs 
were transfected at a final concentration of 50 nM each into monolayers of Huh-7 
cells (a gift from Yu-Jui-Yvonne Wan, KUMC) seeded in six-well plates using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. 
Control siRNA was similarly transfected into control wells. Twelve hours after 
transfection, GW-182 and Ge-1 siRNA or control siRNA was retransfected 
together with 4 µg of pCDNAGFPns plasmid. The effect of siRNA knockdown on 
the expression levels of GW-182 and Ge-1 proteins was verified 24 h after first 
transfection by Western blot analysis, using either anti-GW182 or anti-Ge-1 
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antibodies (Santa Cruz). Cells were infected with SNV at an MOI of 1.0, 24 h 
after first transfection. Cells were lysed 36 h postinfection, and total RNA was 
purified and reverse transcribed using a primer specific to the S-segment mRNA, 
as mentioned in the “Reverse transcription and real-time PCR” section above. 
The effect of siRNA knockdown on hantavirus cap snatching was monitored by 
quantitative estimation of caps snatched from the GFPns mRNA by the SNV 
RdRp, using real-time PCR analysis, as discussed in the above “Reverse 
transcription and real-time PCR” section. 
To determine the effect of a P body on the protection of mRNA caps by SNV N 
protein, monolayers of Huh-7 cells were either mock transfected or transfected 
with both GW-182 and Ge-1 siRNAs at a final concentration of 50 nM each. 
Twelve hours posttransfection, cells were retransfected with GW182 and Ge-1 
siRNAs along with 4 µg each of plasmids pCDNAGFPns and pCDNA-SNVN. 
Cells were lysed 24 h after plasmid transfection, and total RNA was purified. Two 
micrograms of total RNA was reverse transcribed using random primers. The 
cDNA generated from both mock- and siRNA-transfected cells was used in real-
time PCR analysis to quantitatively estimate the 5′ terminus of GFPns mRNA, 
using a forward primer, 5′-TAGAGAACCCACTGCTTACTGGC-3′, and a reverse 
primer 5′-CAGATGAACTTCAGGGTCAG-3′. 
5′ RACE. 5′ RACE was performed using a 5′/3′ RACE kit (catalog no. 
03353621001; Roche Applied Science) following the manufacturer's instruction. 
Briefly, Vero E6 cells seeded in six-well plates were transfected with 4 µg of 
either pCDNAGFP or pCDNAGFPns plasmid or cotransfected with 2 µg of each 
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GFP mRNA and nonsense GFP mRNA and synthesized by in vitro T7 
transcription. Eight hours posttransfection, cells were infected with Sin Nombre 
virus at an MOI of 10. Cells were lysed 48 h postinfection, and total RNA was 
purified using the RNeasy kit (Qiagen). Two micrograms of purified total RNA 
was reverse transcribed using a primer, 5′-
ACTAAAGCCAATCACACCCATGACA-3′, complementary to the S-segment 
mRNA from 696 to 720 nucleotides. The resulting cDNA was purified using a 
PCR cleanup kit (Qiagen), and a homopolymeric (dA) tail was added at the 3′ 
end of the cDNA, using terminal transferase provided in the kit. The (dA)-tailed 
cDNA was then used to generate a PCR product with the forward oligo(dT)-
anchor primer 5′-GACCACGCGTATCGATGTCGACTTTTTTTTTTTTTTTTV-3′ (V 
= A, C, or T) and a reverse primer, 5′-GCGAAACTTAGAATGTAGAGTCCGATG-
3′. The reverse primer was complementary to the S-segment mRNA from 405 to 
431 nucleotides. Finally, the resulting PCR product was used as a template to 
generate a short PCR product using the anchor primer (5′-
GACCACGCGTATCGATGTCGAC-3′) containing a MluI site and a reverse 
primer (5′-ATTATATAGCGGCCGCATGGTCATCAGGTTCAATCC-3′) containing 
a NotI site. The reverse primer was complementary to the S-segment mRNA 
from 290 to 309 nucleotides. The final PCR product was digested with MluI and 
NotI and cloned in pcDNA 3.1+ vector between the same restriction sites. The 
plasmid DNA isolated from 20 colonies was sequenced to read the cap-UTR 
junction of the S-segment mRNA. 
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Staining and microscopy. Adherent Huh-7 cells were grown on sterilized glass 
coverslips in a six-well plate. Cells were transfected with either GW182 siRNA 
(IDT) or Ge-1 siRNA (IDT) using Lipofectamine RNAiMax (Invitrogen) according 
to the manufacturer's instructions. Similarly, the control siRNA was transfected 
into the control well. After 24 h, cells were fixed at −20°C for 5 min using acetone 
and then permeabilized with 0.5% Triton X-100 at room temperature for 15 min. 
Cells were then incubated for 1 h at room temperature with rabbit anti-Dcp2 
antibody at a dilution of 1:100 in phosphate-buffered saline (PBS) containing 2% 
fetal calf serum (FCS). After washing with PBS, cells were incubated for 1 h at 
room temperature with fluorescein isothiocyanate (FITC)-conjugated anti-rabbit 
IgG antibody at a 1,000-fold dilution in PBS containing 2% FCS. Fluorescent 
images were recorded by a Nikon Eclipse 80i upright microscope. 
Synthesis of mRNA and 5′ capping. The mRNA synthesis was carried out 
using the Ribomax T7 transcription kit (Promega) as previously reported [37, 
141, 146, 166]. Briefly, the gene of interest was PCR amplified using a forward 
primer containing a flanking T7 promoter and an appropriate reverse primer. The 
PCR product was gel purified and used as the template in a 50-µl transcription 
reaction. Following synthesis, template DNA was degraded with DNase I, and 
RNA was purified by RNAeasy (Qiagen) and stored in 10-µl aliquots at −70°C. 
The resulting mRNA was 5′ capped using the ScriptCap m7G capping system 
(Cell Script Catnumber C-SCCE0610), according to the manufacturer's 
instructions. Briefly, 50 µg of purified mRNA was added to the reaction mix 
containing 50 mM Tris HCl, pH 8.0, 6 mM KCl, 1.25 mM MgCl2, 1 mM GTP, 100 
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µM S-adenosyl-methionine (SAM), and 1 unit of the capping enzyme in a final 
volume of 100 µl. The reaction mixture was incubated at 37°C for 30 min, 
followed by purification of capped mRNA using the RNeasy kit (Qiagen). The 
purified capped mRNA was used to transfect Huh-7 cells. 
Using this approach, we also synthesized GFP mRNA and nonsense GFP 
mRNA, which were cotransfected to Huh-7 cells to examine whether 
hantaviruses preferentially snatch caps from nonsense transcripts. Briefly, the 
GFP ORF was PCR amplified from pCDNAGFP plasmid using a forward primer, 
5′-
CTAGCTAATACGACTCACTATAGTAGAGAACCCACTGCTTACTGGCTTATCG
-3′, and a reverse primer, 5′-CCATAGAGCCCACCGCATCCCC-3′. Similarly a 
forward primer, 5′-
CTAGCTAATACGACTCACTATAGTAGAGAACCACCTGCTTACTGGCTTATCG
-3′, and the above-described reverse primer were used to generate another PCR 
product from plasmid pCDNAGFPns. Both the PCR products were gel purified 
and used as the templates to generate two transcripts, as described above. The 
two transcripts were 5′ capped using the ScriptCap m7G capping system, as 
described above. The 3′ tailing of purified capped mRNAs was carried out using 
a Cell Script A-Plus poly(A) polymerase tailing kit, following the manufacturer's 
instructions. Briefly, 50 µg of purified capped GFP mRNA or nonsense GFP 
mRNA were mixed with 1× tailing buffer (50 mM Tris-HCl, pH 8.0, 250 mM NaCl, 
and 10 mM MgCl2) containing 10 mM ATP and 8 units of Cellscript A-plus 
poly(A) polymerase in a total volume of 50 µl. The reaction mixture was 
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SNV preferentially snatches caps from mRNAs containing premature 
termination codons. We have previously reported that hantavirus N protein 
efficiently protects the 5′ caps of cellular nonsense mRNAs in comparison to 
mRNAs, which encode proteins [37]. The protected caps were abundantly found 
in cellular P bodies, which were later efficiently used by the RdRp for 
transcription initiation [37]. To further confirm this observation, we cloned GFP in 
the pCDNA3.1+ vector, which expresses GFP mRNA having 5′ and 3′ UTRs of 
71 and 372 nucleotides in length, respectively (Fig. 2E). In addition, we 
incorporated two extra nucleotides in the open reading frame (ORF) of the GFP 
expression construct, which generated a premature termination codon two amino 
acids downstream of the start codon (Fig. 2E). We transfected Vero E6 cells with 
these GFP constructs expressing either GFP mRNA or nonsense GFP mRNA, 
followed by infection with SNV 8 h posttransfection. We used our previously 
established cap-snatching assay to quantitatively estimate the caps snatched 
from either GFP mRNA or GFP nonsense mRNA by the viral RdRp. Briefly, 48 h 
postinfection, cells were lysed and total RNA was purified and reverse 
transcribed using a primer specific to the S-segment mRNA (Fig. 2A; also see 
Materials and Methods). The cDNA was PCR amplified using a forward primer 
specific to the 5′ terminus of GFP mRNA and a reverse primer specific to the N 
protein open reading frame (ORF) (Fig. 2A). This PCR strategy was designed to 
specifically identify the S-segment mRNAs, which have obtained their 5′ caps 
from either GFP mRNA or GFP nonsense mRNA. As expected, this PCR 
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strategy generated the PCR product of appropriate size only from SNV-infected 
cells that were previously transfected with the constructs expressing either GFP 
mRNA or GFP nonsense mRNA (Fig. 2B). A comparatively intense band from 
cells expressing GFP nonsense mRNA suggests that RdRp preferentially 
snatches caps from PTC-containing mRNAs. To rule out the possibility that the 
difference in the band intensities shown in Fig. 2B was not due to a difference in 
the intrinsic steady-state levels of GFP mRNA and GFP nonsense mRNA in host 
cells, we repeated the above-described experiment and quantitatively estimated 
the expression levels of these two transcripts using real-time PCR. As shown in 
Fig. 2C, the intrinsic steady-state levels of GFP mRNA were 3-fold higher than 
those of GFP nonsense mRNA, consistent with preferential degradation of PTC-
containing mRNA by host NMD machinery. To further confirm the observation 
made in Fig. 2B that SNV RdRp preferentially snatches caps from PTC-
containing mRNAs, we used our previously established real-time PCR-based 
cap-snatching method to quantitatively estimate the caps snatched by the S-
segment mRNA from either GFP mRNA or GFP nonsense mRNA. Consistent 
with the observations made in Fig. 2C, we observed that although intrinsic 
steady-state levels of GFP nonsense mRNA were lower than those of GFP 
mRNA, the PTC-containing GFP mRNA served as a better cap donor than GFP 
mRNA (Fig. 2D). 
In addition, we used 5′ RACE to examine the 5′ terminus of S-segment mRNA 
and to further confirm that SNV RdRp preferentially uses the PTC-containing 
mRNAs for cap snatching. We expressed either GFP mRNA or GFP nonsense 
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mRNA in virus-infected Vero E6 cells and examined the 5′ terminus of S-segment 
mRNA by 5′ RACE to further confirm that GFP nonsense mRNA serves as a 
preferential cap donor in comparison to GFP mRNA. The PCR product 
corresponding to virus-infected cells expressing either GFP mRNA or GFP 
nonsense mRNA was cloned, and plasmid DNA isolated from 20 colonies was 
sequenced (see Materials and Methods for details). Interestingly, 19 of 20 
colonies were positive for cap snatching from GFP nonsense mRNA, suggesting 
that SNV RdRp snatched 95% of the caps from GFP nonsense mRNA in virus-
infected cells expressing this transcript. In comparison, 1 of 20 colonies was 
positive for cap snatching from GFP mRNA, suggesting that only 5% of caps 
were snatched from GFP mRNA in virus-infected cells expressing this transcript 
(data not shown). Thus, both 5′ RACE and real-time PCR analysis suggest that 
the cap-donating potential of nonsense GFP mRNA is ∼25-fold higher than that 
of GFP mRNA. 
To further strengthen this observation, we synthesized the GFP mRNA and 
nonsense GFP mRNA by in vitro T7 transcription, as described in Materials and 
Methods. Both the mRNAs were capped at the 5′ terminus and polyadenylated at 
the 3′ terminus (see Materials and Methods). To differentiate the 5′ UTRs of GFP 
mRNA and nonsense GFP mRNA, we mutated the 10th and 11th residues 
downstream of the terminal cap in the 5′ terminus of GFP mRNA from CA to AC 
(Fig. 2F). We cotransfected Vero E6 cells with GFP mRNA and nonsense GFP 
mRNA, followed by viral infection. Total RNA was purified from infected cells, and 
5′ RACE was again used to examine the 5′ terminus of viral S-segment mRNA, 
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as described above. An examination of 15 colonies revealed that 13 out of 15 
colonies were positive for cap snatching from nonsense GFP mRNA. One colony 
each was positive for cap snatching from GFP mRNA and cellular mRNA. Taken 
together, these observations strongly establish that hantaviruses preferentially 
snatch caps from nonsense mRNAs. 
It has been previously reported that hantavirus RdRp preferentially cleaves the 
host cell mRNA at a G residue during cap snatching[37, 69]. To confirm these 
hallmarks of correct cap snatching, the PCR products from Fig. 2B were cloned 
in a TA cloning vector (Invitrogen), and plasmid DNAs from 20 random clones 
were sequenced to examine the cap-UTR junction. Although the assay is not 
quantitative, it is evident from Fig. 2E that capped mRNAs are cleaved at G 
residues, with a preference for the 14th G residue downstream of the 5′ cap. In 
addition, this observation further confirms the specificity of the PCR-based cap-
snatching assay. Similar observations were made from the 5′ RACE experiment 
(Fig. 2F). 
 
SNV preferentially cleaves the host mRNA at a G residue 14 nucleotides 
downstream of the terminal cap. Since PTC-containing GFP mRNA was 
preferentially used for cap snatching, this mRNA was further examined to 
demonstrate the characteristics of the 5′ mRNA termini that are prerequisite for 
cap snatching. Both wild-type and PTC-containing GFP mRNAs contain five G 
residues in the first 30-nucleotide region of the 5′ UTR (Fig. 2E). Using site-
directed mutagenesis, we first mutated these five G nucleotides to C residues 
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(pCDNAGFPnsG0) and asked whether the resulting mutant mRNA was still an 
efficient cap donor for the hantavirus cap snatching (Fig. 3A). We used a real-
time PCR analysis to quantitatively estimate the caps obtained by the S-
segment. 
 
Sequence complementarity between the 3′ termini of the capped primer and 
viral genomic RNA favors cap snatching. To determine whether the 
complementarity between the nucleotides at the 3′ terminus of viral genomic RNA 
and the nucleotides located in the vicinity of the high-priority cleavage site (14th 
G residue) of the cap donor mRNA improves the efficiency for cap donation, we 
generated five additional mutants (Fig. 4A). The mutants pCDNAGFPns(i) and 
pCDNAGFPns(ii) express mRNAs having either two or three nucleotides at 
positions 13 to 14 or 12 to 14, respectively, complementary to the 3′ terminus of 
the viral genomic RNA (Fig. 4A). Similarly, three other mutants, 
pCDNAGFPns(iii), pCDNAGFPns(iv), and pCDNAGFPns(v), which have either 
three, six, or nine nucleotides complementary to the 3′ terminus of viral genomic 
RNA were generated (Fig. 4A). The mutant plasmids were transfected into Vero 
E6 cells, followed by viral infection, and caps obtained by the S-segment mRNA 
from the corresponding mutant mRNAs were quantified by real-time PCR, using 
the universal primer set. It is evident from Fig. 4B that a gradual increase in the 
nucleotide complementarity significantly enhances preferential usage of caps 
from the test mRNA during cap snatching. Although it has been previously 
reported that cleavage of capped mRNAs by the endonuclease subunit of 
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influenza virus RdRp occurs independent of the 3′ terminus of viral genomic 
RNA[173], the recent findings suggest that influenza virus transcriptase also 
prefers capped primers with 3′ nucleotides more complementary to the 3′ 
terminus of viral genomic RNA[63]. 
 
SNV snatches caps from its own mRNA. SNV preferentially snatched caps 
from the transcripts containing 5′ nucleotides complementary to the 3′ terminus of 
the viral genomic RNA (Fig. 4B). Caps were snatched with remarkable efficiency 
from the GFP nonsense transcript having a nine-nucleotide-long triplet repeat 
sequence (UAGUAGUAG) in the 5′ UTR, which is complementary to the 3′ 
terminus of viral genomic RNA (Fig. 4B). All hantaviral mRNAs contain this triplet 
repeat sequence at the same location, raising a question of whether hantaviruses 
snatch caps from their own mRNAs during infection. To test this hypothesis, we 
cloned the gene encoding the hantavirus glycoprotein precursor (GPC) along 
with 5′ and 3′ UTRs in the ptriEX1.1 vector. A PCR product was generated from 
the resulting plasmid using a forward primer containing a flanking 5′ T7 promoter 
preceded by the 14 nucleotides of the 5′ UTR of the GFP mRNA and a reverse 
primer containing a flanking 5′ poly (A) tail of 50 nucleotides in length. The 
resulting PCR was used as the template in a T7 transcription reaction for the 
synthesis of GPC mRNA (see Materials and Methods for details). The purified 
mRNA was capped at the 5′ terminus, as described in Materials and Methods. 
This capping method incorporates cap 1 structure, predominantly found in all 
higher eukaryotic mRNA[174]. The cap 1 structure was found to be required for 
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priming the transcription of influenza virus mRNA[62]. The synthesis of GPC 
mRNA was performed in such a way that the 5′ 14 nucleotides of the GPC 
transcript matched all other transcripts used in this study (Fig. 5A). In addition, 
the synthesized GPC mRNA also matched the transcript generated by the viral 
RdRp. Similarly; we synthesized the GPCns mRNA containing a PTC 15 amino 
acids downstream of the initiating methionine (Fig. 5A). For comparison, we also 
synthesized GFP mRNA and GFP nonsense mRNA using T7 RNA polymerase 
(Fig. 5A). Vero E6 cells were transfected with these mRNAs, and the expression 
of GPC and GFP was monitored by Western blot analysis. Unlike nonsense 
mRNAs, the GFP and GPC expression was observed in cells transfected with 
GFP mRNA and GPC mRNA, respectively (Fig. 5B, inset). The cap-donating 
potential of these four transcripts (Fig. 5A) was quantified by a real-time PCR, 
using the primer set shown in Fig. 2A. As shown in Fig. 5B, SNV snatched caps 
from both mRNAs encoding either GFP or viral GPC protein. However, both GFP 
and GPC mRNAs harboring PTCs served as efficient cap donors in comparison 
to their respective wild-type mRNAs. Moreover, it is noticeable from Fig. 5B that 
in comparison to GFP nonsense mRNA, SNV preferentially snatched caps from 
its own mRNA having a PTC. 
Since GPC generates two transmembrane proteins, Gn and Gc, the translation of 
GPC mRNA occurs on the endoplasmic reticulum (ER). The GFP is a soluble 
cytoplasmic protein; it is likely that GFP mRNA is translated by the cytoplasmic 
ribosomes. Thus, the possibility that hantaviruses preferentially snatch caps from 
nonsense mRNAs associated with ER cannot be ruled out. 
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Role of cellular P bodies in hantavirus cap snatching. We have previously 
reported that capped host mRNA oligoribonucleotides bound with SNV N protein 
were abundantly found in cellular P bodies that were later efficiently used as 
primers by the hantavirus RdRp for transcription initiation (42). It is possible that 
N independently migrates to P bodies and selectively associates with the 5′ caps 
of those cellular transcripts that are transported to P bodies for degradation. 
Alternatively, it is equally likely that N independently associates with the mRNA 5′ 
caps in the cytoplasm and migrates to P bodies along with bound mRNAs, which 
are targeted to P bodies for degradation. To test these two possibilities and to 
demonstrate the general role of cellular P bodies in hantavirus cap snatching, we 
used siRNAs to downregulate GW182 and Ge-1 proteins in Huh-7 cells. 
Downregulation of Gw182 and Ge-1 was confirmed by Western blot analysis 
(Fig. 6A and B). Both Gw182 and Ge-1 are critical P-body components whose 
downregulation has been reported to cause P-body loss in cells [98, 175]. The 
decapping enzyme Dcp2 is a P-body resident and a commonly used marker to 
examine the P-body formation in cells. Using an anti-Dcp2 antibody, the P-body 
formation in wild-type and siRNA-downregulated Huh-7 cells was examined by 
fluorescence microscopy. As evident from Fig. 6C, the downregulation of GW182 
and Ge-1 causes P-body loss in Huh-7 cells. 
We next asked whether SNV N can bind to the 5′ caps and equally protect the 5′ 
terminus of the nonsense mRNA in wild-type and P-body-deficient Huh-7 cells. If 
N selectively protects the 5′ caps of cellular mRNAs in P bodies, we do not 
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expect such protection in Gw182-deficient cells. We cotransfected the wild-type 
and P-body-deficient Huh-7 cells with a pCDNAGFPns construct expressing 
nonsense GFP mRNA along with a plasmid expressing SNV N protein. At 36 h 
posttransfection, cells were lysed and total RNA was purified and reverse 
transcribed using random primers, as previously reported [37]. The 5′ terminus of 
GFP nonsense mRNA was quantitatively estimated by real-time PCR analysis 
using a primer set targeted to amplify 180 nucleotides at the 5′ terminus of the 
mRNA, as previously reported [37]. As shown in Fig. 6D, the loss of P-body 
machinery resulted in the protection of the 5′ mRNA terminus independent of N 
protein expression. This protection was likely due to the inefficient decapping 
machinery in P-body-downregulated cells [98, 175]. Interestingly, we observed a 
remarkable protection of the 5′ mRNA terminus by SNV N in both wild-type and 
P-body-downregulated cells. This observation suggests that SNV N likely binds 
to the capped host cell mRNAs in the cytoplasm outside the P bodies. To 
delineate whether P bodies play a role in hantavirus cap snatching and viral 
mRNA synthesis, we transfected the Huh-7 cells with the cap donor plasmid 
pCDNAGFPns, followed by the viral infection. The cap-snatching efficiency by 
SNV RdRp in P-body-deficient Huh-7 cells was compared with that of wild-type 
Huh-7 cells having intact P-body machinery. Since the protection of the 5′ mRNA 
terminus by N protein in P-body-deficient cells was around 2-fold greater than 
that in the wild-type Huh-7 cells (Fig. 6D), we expected corresponding increases 
in cap snatching in P-body-deficient cells. Interestingly, we observed that cap 
snatching, and hence viral mRNA synthesis, was not improved in P-body-
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deficient cells compared to that in wild-type cells (Fig. 6E). This observation 
























The viral genome of negative-sense RNA viruses is encapsidated into viral 
nucleocapsids, which serve as templates for RdRp during transcription and 
replication of the viral genome[176, 177]. The negative-strand segmented RNA 
viruses of the Orthomyxoviridae (e.g., influenza A, B, and C and Thogoto 
viruses), Bunyaviridae (e.g., La Crosse, hanta, Rift Valley fever, and Crimean-
Congo hemorrhagic fever viruses) and Arenaviridae (e.g., Lassa virus) families 
synthesize the translation-competent capped mRNAs by the cap-snatching 
mechanism. This mechanism has been well studied for the influenza virus, 
having an RdRp composed of three subunits, PA, PB1, and PB2. The PB1 
subunit contains a conserved polymerase domain, which carries out RNA 
elongation during RNA synthesis[152]. The PB2 subunit binds to the 5′ caps of 
host pre-mRNAs[64, 66], and the PA subunit has the endonuclease domain, 
which cleaves the capped pre-mRNAs 10 to 13 nucleotides downstream of the 5′ 
cap[67, 153]. The capped oligoribonucleotides are used as primers by the viral 
RdRp to initiate the transcription. The presence of an endonuclease domain in 
the RdRps of several other viruses, including SNV, has recently been 
proposed[52, 163]. However, it is not yet clear whether, similarly to that in 
influenza viruses, the entire cap-snatching process in these viruses is carried out 
solely by the RdRp or other host factors or whether viral proteins also play a role. 
Sequence analyses of many viral mRNA 5′ termini have revealed a nucleotide 
preference at the 3′ end of the capped primer, which has been assumed to reflect 
the sequence preference for cleavage by the viral endonuclease during cap 
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snatching. For example, in the case of Dugbe virus endonucleolytic cleavage is 
assumed to take place after a C residue[159], whereas for Bunyamwera virus a 
strong preference for cleavage after a U residue has been proposed[51]. In 
tomato spotted wilt virus, preference for an A residue has been confirmed[178]. 
However, it has been reported that influenza virus RdRp effectively uses only 
CA-terminated capped fragments as primers for viral mRNA synthesis in vitro. 
Consistent with our previous observation[37], we have found that primers used 
by the SNV RdRp are terminated at G residues. Taking these observations into 
consideration, it is likely that RdRps have a preference for the endonucleolytic 
cleavage at certain nucleotides in the mRNA sequence. However, it is also 
possible that RdRps randomly cleave the capped mRNAs and that the resulting 
capped fragments with appropriate terminal nucleotides are selected as primers. 
The selection may depend upon the appropriate location of complementary 
nucleotides at the 3′ terminus of the vRNA template.  
Previous studies have reported that most viruses use 15-nucleotide-long capped 
primers with a variation of 10 to 20 nucleotides for transcription initiation [133, 
150, 151, 154, 157-161]. However, viruses of the Arenaviridae and the nairovirus 
genus use relatively shorter primers, varying in length from 1 to 4 and 5 to 16 
nucleotides, respectively[69, 156, 159]. We observed that SNV has a strong 
preference for 14-nucleotide-long primers containing a 3′-terminal G residue. It is 
still a mystery why the RdRps from different viruses use capped primers of 
various lengths for the transcription initiation. A possible role of the length of a 
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capped primer in transcription initiation has been suggested in the cap-snatching 
model (Fig. 7).  
In hantaviruses, the capped primer containing a 3′ G residue has been proposed 
to undergo base pairing with one of the C residues at the 3′ terminus of the vRNA 
template during transcription initiation[69]. It has been suggested that RdRp 
elongates the annealed primer during transcription initiation using a “prime and 
realign” mechanism[37, 69]. However, it is interesting to imagine how a single G-
C base pairing between the RNA primer and 3′ terminus of the vRNA template 
stabilizes the primer and favors its annealing. We have previously reported that 
hantavirus N protein stabilizes a capped primer at the 3′ terminus of the vRNA 
template[32]. We showed that N protein binds the mRNA caps and has distinct 
cap and RNA binding sites[36, 37]. N protein with a capped primer loaded at its 
cap-binding site simultaneously binds the 3′ terminus of the vRNA template with 
specificity and facilitates the annealing of the capped primer with the template, 
which favors transcription. To further address the annealing of the capped primer 
with the vRNA template during the cap-snatching mechanism of transcription 
initiation, we asked whether the complementarity between the 3′ termini of the 
primer and vRNA template favors cap snatching. We incorporated two 
nucleotides preceding the high-priority cleavage site (14th G) in the 3′ terminus of 
test mRNA which were complementary to the 3′ terminus of the genomic RNA 
(Fig. 4A). Similarly, either three, six, or nine nucleotides complementary to the 3′ 
terminus of the vRNA template were incorporated in the test mRNA, preceding 
the 14th G residue (Fig. 4A). These complementary nucleotides contained G 
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residues, which can also serve as low-priority cleavage sites for the RdRp. An 
examination by a very sensitive real-time PCR method demonstrated that these 
test mRNAs served as efficient cap donors during cap snatching. These 
observations support the recent findings that although the cleavage of capped 
mRNAs by the endonuclease subunit of influenza RdRp occurs independent of 
the 3′ terminus of viral genomic RNA[173], the influenza virus transcriptase 
prefers capped primers with 3′ nucleotides more complementary to the 3′ 
terminus of viral genomic RNA[63]. We propose that for an mRNA to be an 
efficient cap donor during cap snatching, it must contain a high-priority cleavage 
site at an appropriate length from the 5′ terminus. For example, an mRNA having 
a G residue at the 14th position will be the preferred cap donor for hantavirus cap 
snatching. In addition, the nucleotide complementarity between the 3′ termini of 
the capped primer and vRNA template favors the annealing of the primer with the 
vRNA template.  
Although the basic mechanism for the generation of capped primers of 
appropriate length and specificity might be similar between the RdRps of 
influenza virus and SNV, the basic difference in their cap-snatching mechanism 
would be due to their replications at different locations in the host cell. The 
cellular mRNAs are engaged in translation in the cell cytoplasm and are targeted 
to P bodies for degradation after the completion of translation. Thus, unlike 
influenza virus, whose replication takes place in the nucleus, the viruses 
replicating in the cytoplasm, such as SNV and Rift Valley Fever virus, have to 
effectively compete with the host decapping machinery to protect the mRNA caps 
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from degradation. We have previously reported that hantavirus N protein actively 
protects the host mRNA caps from degradation[37]. N binds to the host mRNA 
caps and likely blocks the binding of the decapping enzyme DCP2 at the mRNA 
5′ cap by competitive inhibition, which would result in the protection of host 
mRNA caps from degradation. The rescued 5′ capped RNA oligoribonucleotides 
were sequestered in the cellular P bodies by N and were later efficiently used as 
primers by the RdRp. These observations raised the questions of whether N 
binds to the mRNA caps in the cytoplasm or inside the P bodies and whether P 
bodies have any role in the cap-snatching process. Protection of host mRNA 
caps in P-body-downregulated cells support the idea that N likely binds the 
mRNA caps inside the cytoplasm. N protein is likely transported to the P bodies 
along with the mRNAs, which are targeted for degradation after the completion of 
translation. Although N rescued the mRNA caps in P-body-deficient cells, the 
rescued caps were not used with significant efficiency in comparison to cells 
having intact P-body machinery. These observations suggest that P bodies might 
play a role in virus replication by providing the capped primers with high 
efficiency for the transcription initiation. Alternatively, a possible role of a P-body 
component in hantavirus cap snatching cannot be ruled out. Further 
experimentation is required to demonstrate the exact role of cellular P bodies in 
the cap-snatching process. A critical observation that PTC-containing mRNAs 
were remarkably efficient cap donors in comparison to the wild-type mRNAs 
suggests that efficiency of an mRNA to donate caps for viral mRNA synthesis is 
regulated primarily at the translation process. An mRNA engaged in translation 
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may not be an efficient cap donor even if it contains a potential G residue at the 
14th position or contains a sequence more complementary to the 3′ terminus of 
the viral RNA template. We propose that hantaviruses obtain most of their caps 
from the mRNAs, which abort translation due to PTCs or other translation 
defects.  
The interesting observation that hantaviruses can snatch caps from their own 
mRNAs is consistent with the positive role of the nucleotide complementarity 
between the 3′ termini of the capped primer and the vRNA template in cap 
snatching. However, the cap-donating efficiency of wild-type mRNAs is negligible 
in comparison to that of the nonsense mRNAs; it is unlikely that viral mRNAs will 
be efficiently used for cap snatching during viral infection due to their continued 
engagement in the translation. We found that viral mRNAs containing a PTC 
were remarkably used for cap snatching with high efficiency. Hantavirus RdRp 
lacks proofreading activity. The promiscuous nature of polymerization by RdRps 
due to the lack of proofreading ability is thought to be the primary source of 
evolution in RNA viruses, which provides them an ability to replicate in different 
hosts and produce more pathogenic strains. An error rate of approximately 1 
mutation/replication/genome for hantaviruses has been estimated. Although this 
mutation rate is negligible, the nonsense mRNAs generated due to the lack of 
proofreading activity of the RdRp will be actively recycled for cap snatching. We 
suggest that apart from helping in the evolutionary strategies of the virus, the lack 
of proofreading activity of the RdRp plays a role in cap snatching. A model 
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depicting the role of N protein and cellular P bodies in hantavirus cap snatching 










Figure 2 Hantavirus cap-snatching assay.  
(A) A diagrammatic representation of the cap-snatching assay. Step 1, Vero E6 
cells were transfected with cap donor plasmid (pCDNAGFPns or pCDNAGFP) 
followed by SNV infection 4 h posttransfection (step 2). Step 3, cells were lysed 
48 h postinfection, and total RNA was purified as described in Materials and 
Methods. Twenty-five nanograms of the purified RNA was reverse transcribed 
using a primer specific to the S-segment-derived mRNA. The cDNA was PCR 
amplified using a forward primer specific to the 5′ terminus of GFP mRNA 
(purple) and a reverse primer specific to the N gene (black). See Materials and 
Methods for details. (B) As expected, the PCR product was generated only from 
the cells which were transfected with either pCDNAGFPns or pCDNAGFP 
plasmid, followed by viral infection. (C) The Vero E6 cells were transfected with 
cap donor plasmid pCDNAGFPns or pCDNAGFP, followed by SNV infection 4 h 
posttransfection, as described for panel A. Cells were lysed 48 h postinfection, 
and total RNA was purified. Intrinsic mRNA levels expressed from cap donor 
plasmids pCDNAGFPns and pCDNAGFP were quantified by real-time PCR 
analysis using a primer set specific to the GFP open reading frame, as described 
in Materials and Methods. (D) Similarly, the cap-donating potential of the 
transcripts expressed from cap donor plasmids pCDNAGFPns and pCDNAGFP 
was determined by real-time PCR using a primer set shown in panel A. (E) The 
PCR product from panel B was cloned in a TA cloning vector (Invitrogen), and 
plasmid DNA from 20 random clones was sequenced to examine the cap-UTR 
junction. As shown at the bottom, the capped primers were terminated at the 3′ G 
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residue. (F) The GFP mRNA and nonsense GFP mRNA were synthesized by in 
vitro T7 transcription, as described in Materials and Methods. To distinguish their 
5′ UTRs, two nucleotides in the 5′ UTR of nonsense GFP mRNA were mutated 
(bold and underlined). Vero E6 cells were cotransfected with GFP mRNA and 
nonsense GFP mRNA, followed by virus infection. The cap-donating potential of 











Figure 3 Characteristics of a preferred cap donor mRNA for hantavirus cap 
snatching.  
(A) To determine the characteristics of the 5′ mRNA termini that are required for 
cap snatching, we generated multiple constructs, shown on the left side. The 
mRNA encoded by each plasmid is shown by an arrow. The bold letters show the 
mutations in the 5′ mRNA terminus. The universal primer set used in the real-
time PCR studies is shown at the bottom. (B) Vero E6 cells were transfected with 
the plasmids shown in panel A, followed by SNV infection. Total mRNA was 
purified and reverse transcribed using a primer specific to the S-segment mRNA. 
Using the universal primer set, the cDNA was used in real-time PCR analysis to 
quantify the caps obtained by the S-segment mRNA from the mutant mRNAs 

















Figure 4 Role of nucleotide complementarity in hantavirus cap snatching.  
(A) To determine whether nucleotide complementarity at the 3′ termini of viral 
genomic RNA and the capped primer have a role in cap snatching, we generated 
five additional plasmids, shown on the left side. The mRNAs expressed from 
these plasmids are shown by arrows. The bold letters show the mutations in the 
5′ mRNA terminus. The complementary nucleotides between the test mRNA and 
the viral genomic RNA are shown. (B) Vero E6 cells were transfected with the 
plasmids shown in panel A, followed by SNV infection. Total mRNA was purified 
and reverse transcribed using a primer specific to the S-segment mRNA. Using 
the universal primer set, the cDNA was used in real-time PCR analysis to 
quantify the caps obtained by the S-segment mRNA from the mutant mRNAs 
expressed from the transfected plasmids shown in panel A (see Materials and 











Figure 5 SNV snatches caps from its own mRNA.  
(A) To determine whether hantaviruses snatch caps form their own mRNAs, we 
synthesized SNV glycoprotein precursor (GPC) mRNA and GPC nonsense 
mRNA by T7 transcription reaction, as described in Materials and Methods. The 
two mRNAs are the same in sequence except that nonsense GPC mRNA has 
two additional CC residues in the GPC ORF four amino acids from the initiating 
methionine. This additional mutation generated a stop codon 15 amino acids 
downstream of the initiating methionine. For comparison we synthesized GFP 
mRNA and nonsense GFP mRNA using a T7 transcription reaction, as described 
in Materials and Methods. GFP mRNA and nonsense GFP mRNA are the same 
in sequence except that nonsense GFP mRNA has a PTC two amino acids from 
the initiating methionine. It must be noted that the 5′-terminal 15 nucleotides of all 
these four mRNAs are the same in sequence. (B) Vero E6 cells were transfected 
with the mRNAs shown in panel A, followed by SNV infection. Caps snatched by 
SNV RdRp from these four transcripts were quantified by real-time PCR analysis 
using the universal primer set shown in Fig. 3A (see Materials and Methods for 
details). To ensure that transfected mRNA were properly engaged in translation, 
Vero E6 cells were transfected with the mRNA shown in panel A. Cells were 
lysed 36 h posttransfection, and cell lysates were examined by Western blot 
analysis (inset) using either anti-GFP (i) or anti-His tag (ii) antibody. The GPC 













Figure 6 Role of cellular P bodies in hantavirus cap snatching.  
(A) Downregulation of GW182 by siRNA. To determine whether GW182 was 
downregulated after siRNA treatment, cells transfected with either siRNA or 
control siRNA were lysed and GW182 expression was monitored by Western blot 
analysis using anti-GW182 antibody. To confirm that downregulation of GW182 
observed by Western blot analysis was not a loading error, equal volumes of cell 
lysate were examined for the expression of β-actin by Western blot analysis 
(bottom bands). (B) Similar to what is shown in panel A, the downregulation of 
Ge-1 by siRNA was confirmed by Western blot analysis using anti-Ge-1 antibody. 
(C) Downregulation of GW182 and Ge-1 by siRNA causes the downregulation of 
cellular P bodies. Huh-7 cells were transfected with 150 nM either control siRNA, 
GW-182 siRNA, or Ge-1 siRNA. Twenty-four hours posttransfection, cells were 
fixed with formaldehyde and stained with anti-Dcp2 antibody. Cells were 
visualized under fluorescence microscope using a FITC-conjugated secondary 
antibody. Bar, 10 µm. (D) Wild-type or P-body-downregulated Huh-7 cells were 
cotransfected with pCDNAGFPns and pCDNA-SNVN plasmids, expressing the 
cap donor test mRNA and SNV N protein, respectively. Thirty-six hours 
posttransfection, cells were lysed and total RNA was purified and reverse 
transcribed using random primers. The effect of N upon the stability of the test 
mRNA was quantified by real-time PCR analysis using a forward primer, 5′-
TAGAGAACCCACTGCTTACTGGC-3′, and a reverse primer, 5′-
CAGATGAACTTCAGGGTCAG-3′, to amplify 241 nucleotides from the 5′ mRNA 
terminus. (E) Huh-7 cells transfected with either siRNA or control siRNA along 
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the cap donor plasmid pCDNAGFPns were infected with SNV. Caps snatched by 
the SNV from the test mRNA were quantified by real-time PCR analysis using the 















Figure 7 Hantavirus cap-snatching model.  
(Step 1) An mRNA engaged in translation is not used for cap snatching. N 
protein can bind to the mRNA cap before translation or after the completion of 
translation. (Step 2) N-associated mRNAs are targeted to P bodies for 
degradation. N protects the mRNA caps from degradation in P bodies. The 
rescued 5′-capped mRNA oligoribonucleotides are stored in P bodies by N and 
are efficiently used for cap snatching outside P bodies. Alternatively, N-
associated mRNAs outside the P bodies can be directly used in cap snatching 
with less efficiency. (Step 3) The endonuclease activity of hantavirus RdRp or a 
possible cellular endonuclease preferentially cleaves the capped oligonucleotides 
at G residues. (Step 4) N protein with a capped primer at the cap binding site 
simultaneously binds the 3′ terminus of the viral RNA genome and facilitates the 
annealing of the capped primer with the 3′ terminus of the vRNA template. The 
capped primer with 3′ nucleotides more complementary to the 3′ terminus of 









Interaction between Hantavirus Nucleocapsid Protein (N) and 
RNA-Dependent RNA Polymerase (RdRp) Mutants Reveals the 
Requirement of an N-RdRp Interaction for Viral RNA Synthesis 
 
Abstract 
Viral ribonucleocapsids harboring the viral genomic RNA are used as the 
template for viral mRNA synthesis and replication of the viral genome by viral 
RNA-dependent RNA polymerase (RdRp). Here we show that hantavirus 
nucleocapsid protein (N protein) interacts with RdRp in virus-infected cells. We 
mapped the RdRp binding domain at the N terminus of N protein. Similarly, the N 
protein binding pocket is located at the C terminus of RdRp. We demonstrate that 
an N protein-RdRp interaction is required for RdRp function during the course of 






Results and Discussion 
Hantaviruses are negative-strand emerging RNA viruses and members of the 
Bunyaviridae family. Humans get hantavirus infection by inhalation of aerosolized 
excreta from infected rodent hosts[179-182]. Hantavirus infection causes 
hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary 
syndrome (HCPS), with mortalities of 15% and 50%, respectively[130, 131]. The 
spherical hantavirus particles harbor three genomic RNA segments (S, M, and L) 
within a lipid bilayer [131, 183], encoding viral nucleocapsid protein (N protein), 
viral RNA-dependent RNA polymerase (RdRp), and glycoprotein precursor 
(GPC), respectively. The GPC is posttranslationally cleaved at a highly 
conserved WAASA motif, generating two glycoproteins, Gn and Gc[184]. N 
protein is multifunctional, primarily involved in encapsidation of the viral genome. 
However, recent studies have suggested that N protein plays diverse roles in the 
virus replication cycle. The viral ribonucleocapsids are used as the template by 
viral RdRp for the synthesis of viral mRNA and replication of the viral genome 
[176, 177]. However, it is still a mystery how RdRp accesses the viral RNA 
(vRNA) genome, which is buried inside the compact nucleocapsid structure. 
Moreover, numerous reverse genetic systems have proven that RdRp from 
negative-strand RNA viruses requires assistance from N protein while performing 
its function inside the host cell[139, 185-188]. Based on these observations, we 
asked whether N protein directly interacts with RdRp and regulates its function.  
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To answer this question, we cloned the gene encoding the Sin Nombre virus 
(SNV) RdRp in the pcDNA 3.1 (+) backbone containing either a green fluorescent 
protein (GFP) tag at the N terminus or a His tag at the C terminus. The 
expression construct was transfected into human umbilical vein endothelial cells 
(HUVECs) and HeLa and HEK293T cells for expression. An examination of the 
cell lysate by Western blot analysis did not show the expression of RdRp, which 
was due to lack of RdRp expression and not due to poor antibody reactivity. The 
gene was next cloned in pFastBac vector to examine the expression in Sf9 insect 
cells, using a baculovirus expression system. However, multiple trials revealed 
that RdRp was not expressed in insect cells as well (not shown). Hantavirus 
RdRp is a large protein of 250 kDa. To our knowledge, its structure is not known, 
although two functional domains have been predicted by in silico studies. Similar 
to other segmented negative-strand RNA viruses, the hantavirus RdRp initiates 
transcription by a unique cap-snatching mechanism [149-152, 189]. Based on in 
slico analysis, the regions around amino acids 1 to 250 and 751 to 1290 have 
been proposed to constitute the cap-snatching endonuclease domain and 
catalytic domain, respectively [54]. The regions from amino acids 251 to 750 and 
1291 to 2153 have not been assigned any function (Fig. 8A) [52, 54]. However, 
the analysis by a domain prediction software that identifies conserved protein 
domains suggested the catalytic domain is slightly bigger and corresponds to the 
region from amino acids 562 to 1286. The upstream intervening sequence 
between the endonuclease domain and the catalytic domain constitutes the 
region from amino acids 238 to 562 (Fig. 8A). Since wild-type RdRp was not 
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expressed, we chose to individually express the predicted domains of RdRp in 
mammalian cells and examine their interaction with N protein. We generated 
constructs expressing the N-terminal endonuclease domain (pol1–250), 
intervening region of unknown function (pol251–752), catalytic domain (pol751–
1290), and the C-terminal region of unknown function (pol1291–2153) (Fig. 8A). 
Due to ambiguity in the domain prediction, two additional constructs expressing 
the intervening region (pol238–562) and catalytic domain (pol562–1286) were 
also generated (Fig. 8A). All of these RdRp fragments contained a C-terminal His 
tag. HEK293T cells were cotransfected with plasmids expressing the RdRp 
fragment of interest along with C-terminally myc-tagged N protein. An 
examination of whole-cell lysates (WCL) by Western blot analysis showed that all 
RdRp fragments were expressed in HEK293T cells, except the pol1–250 
fragment. In addition, the pol1291–2153 fragment was truncated from the N 
terminus (Fig. 8B). The Western blot analysis of whole-cell lysates using anti-myc 
antibody revealed the similar expression of N protein in cotransfected HEK293T 
cells, except for the cells coexpressing N protein along with the pol1–250 
fragment. Based on these observations, it is clear that the N-terminal 
endonuclease domain does not accumulate in cells, and it also inhibited the 
accumulation of N protein in cotransfected cells. To determine whether the pol1–
250 fragment specifically inhibited N protein expression, we cotransfected 
HEK293T cells with plasmids expressing the pol1–250 fragment along with 
another plasmid expressing either GFP or the luciferase reporter. Interestingly, 
we observed that the endonuclease domain nonspecifically inhibited the 
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expression of both reporters (not shown). An examination of whole-cell lysates 
(WCL) by Western blot analysis revealed that expression of the pol1–250 
fragment also impacted the expression of endogenous proteins, such as GAPDH 
and tubulin (Fig. 8B). Recently, it has been suggested that the endonuclease 
domain of Andes virus RdRp cleaves the host cell transcripts and also its own 
mRNA and thereby regulates its own as well as host gene expression [70]. It is 
possible that endonuclease activity maintains the lower steady-state levels of 
RdRp in virus-infected cells, which is required for efficient virus replication. As 
mentioned later in this article, we expressed and purified the pol1–250 fragment 
in Escherichia coli. The purified fragment cleaved both capped and uncapped 
mRNAs nonspecifically in vitro (not shown). Moreover, overexpression of the 
pol1–250 fragment showed cytotoxicity in HeLa cells (Fig. 8C). Based on these 
observations, it is likely that endonuclease activity of the pol1–250 fragment 
suppressed its own as well as N protein expression in HEK293T cells (Fig. 8B).  
To determine whether N protein interacts with any of the RdRp fragments, the 
cell lysates were immunoprecipitated with anti-myc antibody, and 
immunoprecipitated material was examined by Western blot analysis using anti-
His tag antibody. It is evident from Fig. 8B that only the pol1291–2153 fragment 
copurified with N protein. Interestingly, the cleavage product of this fragment also 
copurified with N protein. Based on the size of the cleavage product, it is likely 
that the N protein binding domain is located at the C-terminal 400 amino acids of 
RdRp, although this needs further verification. To confirm these observations, 
cell lysates were incubated with Ni-nitrilotriacetic acid (NTA) beads, and the 
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eluted material from washed beads was examined by Western blot analysis 
using anti-myc tag antibody. This experiment further verified the interaction 
between the pol1291–2153 fragment and N protein (Fig. 8B). Since the pol1–250 
fragment was not expressed in transfected cells, we expressed and purified both 
pol1–250 and pol1291–2153 fragments in E. coli using Ni-NTA beads. Cell 
lysates from HEK293T cells expressing C-terminally myc-tagged N protein were 
incubated with either the purified pol1–250 or pol1291–2153 fragment. The 
mixture was immunoprecipitated with anti-myc antibody, and immunoprecipitated 
material was examined by Western blot analysis using anti-His tag antibody. It is 
evident from Fig. 8D that unlike the pol1291–2153 fragment, the pol1–250 
fragment did not bind to N protein. Also, the purified pol1291–2153 fragment from 
E. coli did not contain the truncation product, suggesting that truncation either 
specifically occurs in mammalian cells or the truncation product is unstable in E. 
coli or was lost during the purification process.  
To reexamine the interaction between N protein and the C-terminal 
uncharacterized fragment of RdRp in hantavirus-infected cells, we infected Huh7 
cells with SNV at a multiplicity of infection (MOI) of 2.0, followed by transfection 
with a plasmid expressing the C-terminally His-tagged pol1291–2153 fragment. 
Cell lysates were incubated with Ni-NTA beads. An examination of the eluted 
material from Ni-NTA beads using Western blot analysis confirmed the 
interaction between N protein and the pol1291–2153 fragment (Fig. 8D, top 
panel). To further confirm this interaction in virus-infected cells, the cell lysates 
were immunoprecipitated with anti-N protein antibody, and immunoprecipitated 
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material was examined by Western blot analysis using anti-His tag antibody. It is 
evident from Fig. 8E (bottom panel) that N protein interacts with the pol1291–
2153 fragment in virus-infected cells.  
To directly visualize the interaction between N protein and the pol1291–2153 
fragment, we fused GFP and mCherry reporters at the N terminus of N protein 
and C terminus of the pol1291–2153 fragment, respectively. Similarly, mCherry 
was also fused at the C terminus of the pol238–562 fragment and used as a 
negative control. HeLa cells were cotransfected with plasmids expressing either 
the GFP-N fusion protein along with another plasmid expressing either the 
pol1291–2153 or pol238–562 fragment fused to mCherry. Cells were examined 
under a confocal microscope. As shown in Fig. 9A, both RdRp fragments and N 
protein showed the perinuclear punctate morphology. The green and red puncta 
representing N protein and the pol1291–2153 fragment strongly colocalized with 
each other (Fig. 9A). In comparison, we did not observe a noticeable 
colocalization between N protein and the pol238–562 fragment (Fig. 9A). These 
results are consistent with the specific binding of N protein to the pol1291–2153 
fragment. To visualize the interaction between N protein and the pol1291–2153 
fragment in virus-infected cells, we infected Vero E6 cells with SNV at an MOI of 
2.0. Thirty-six hours postinfection, cells were transfected with a plasmid 
expressing the pol1291–2153 fragment fused to mCherry, as mentioned above. 
N protein was visualized in virus-infected cells by confocal microscopy using a 
fluorescein isothiocyanate (FITC)-conjugated antibody. As shown in Fig. 9B, N 
protein showed a rod-shaped perinuclear morphology, presumably representing 
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the virion RNPs. Again, a noticeable colocalization between the pol1291–2153 
fragment and N protein was observed. The expression of RdRp fragments 
pol238–562 or pol1291–2153 does not seem to influence the N protein 
morphology in virus-infected cells. These results clearly demonstrate that N 
protein interacts with the C-terminal uncharacterized fragment of RdRp.  
To identify the RdRp binding domain in the N protein, we used a panel of both 
the C- and N-terminal deletion mutants of the N protein (Fig. 10A). All of these 
mutants contained a C-terminal His tag. We also modified the pol1291–2153 
expression construct (Fig. 2A) by replacing the C-terminal His tag with a FLAG 
tag. HEK293T cells were cotransfected with a plasmid expressing the FLAG-
tagged pol1291–2153 fragment along with another plasmid expressing the N 
mutant of interest. An examination of whole-cell lysates (WCL) by Western blot 
analysis using anti-N protein antibody revealed that expression levels of few N 
mutants were weaker than those of other ones (Fig. 10B), although differential 
recognition of N protein mutants by anti-SNV N antibody cannot be ruled out. 
However, the levels of expression of the FLAG-tagged pol1291–2153 fragment in 
whole-cell lysates were relatively similar in all samples. Cell lysates were 
immunoprecipitated by anti-FLAG tag antibody, and immunoprecipitated material 
was examined by Western blot analysis using anti-N protein antibody. As shown 
in Fig. 10B, that deletion of up to 252 amino acids from the C terminus (N1–175 
mutant) did not abrogate the interaction between N protein and pol1291–2153 
fragment. In comparison, the deletion of just 50 amino acids from the N terminus 
of N protein abrogated the interaction. To further confirm these results, we 
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incubated the cell lysates with Ni-NTA beads, and the bound material eluted from 
washed beads was examined by Western blot analysis using anti-FLAG 
antibody. It is evident that unlike the N-terminal deletion mutants, all of the C-
terminal deletion mutants bound to FLAG-tagged pol1291–2153 fragment, 
consistent with similar observations from the immunoprecipitation experiment. 
Taken together, these results suggest that the first 50 amino acids at the N 
terminus of N protein constitute the RdRp binding domain. 
To determine whether an N-RdRp interaction plays a role in hantavirus 
replication, we transfected Huh7 cells with a plasmid expressing either the 
pol1291–2153 or pol751–1290 fragment, followed by infection with SNV at an 
MOI of 0.5 16 h posttransfection. Cells were transfected again 36 h postinfection 
to boost the expression of RdRp fragments. Virus replication was monitored over 
time by quantitative estimation of viral S-segment RNA using real-time PCR 
analysis, as previously reported [190]. It is evident that expression of the 
pol1291–2153 fragment significantly inhibited the SNV replication in cells (Fig. 
11A). In comparison, the coexpression of the pol751–1290 fragment, which does 
not bind to N, had no impact upon virus replication. To determine whether the 
pol1291–2153 fragment selectively inhibits SNV replication, we examined the 
effect of this fragment upon the replication of vesicular stomatitis virus (VSV) 
(Fig. 11B) , another negative-strand RNA virus, in the cell culture model. HeLa 
cells grown in 24-well plates were transfected with a plasmid expressing the 
pol1291–2153 fragment, followed by infection with VSV at 103 PFU 16 h 
posttransfection. An examination of virus replication over time revealed that 
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coexpression of the pol1291–2153 fragment had no impact upon the replication 
of VSV, confirming the selectivity inhibition of SNV N by the pol1291–2153 
fragment. Similar results were obtained with hepatitis C virus (HCV) (data not 
shown). 
Due to low expression levels, hantavirus RdRp has never been shown by 
Western blot analysis in virus-infected cells. We speculate that overexpression of 
the pol1291–2153 fragment in virus-infected cells (Fig. 11A) outcompeted wild-
type RdRp for binding to N protein, which resulted in the inhibition of wild-type 
RdRp function. This clearly demonstrates that the N-RdRp interaction plays a 
critical role in the function of RdRp, although the mechanism for such a role is 
still unclear. This is consistent with requirement of N protein expression for RdRp 
function in numerous Bunyaviridae reverse genetic systems[139, 191]. We 
propose that an N-RdRp interaction might play a role in cap snatching. Recently, 
multiple studies have identified the functional manganese-dependent 
endonuclease domain at the N terminus of the Bunyaviridae RdRp that shares a 
type II endonuclease α/β architecture similar to that of the N-terminal 
endonuclease domain of the influenza virus PA subunit[52, 67, 153, 163, 192, 
193]. These studies have led to the proposition that the RdRp endonuclease 
domain functions in cap snatching and is highly conserved among the 
Arenaviridae, Orthomyxoviridae, and Bunyaviridae families. Interestingly, the 
purified endonuclease domain used in these studies [52, 163] nonspecifically 
cleaved the RNA irrespective of the 5′ cap, raising the question of how capped 
primers of the appropriate length and specificity are generated by such a 
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nonspecific cap-snatching endonuclease. The cap-binding activity of hantavirus 
RdRp has not been reported yet, again raising the question of how RdRp is 
loaded onto the mRNA 5′ cap during cap snatching. We previously reported that 
N protein binds to the mRNA 5′ cap. It is likely that simultaneous binding of N 
protein to both the RdRp and the mRNA 5′ cap may recruit RdRp at the mRNA 5′ 
cap for the specific cleavage of capped host cell mRNA to generate RNA primers 
of the appropriate length and specificity. It is possible that overexpressed 
pol1291–2153 fragment (Fig. 11A) competitively inhibited the binding of wild-type 
RdRp with N protein in virus-infected cells, which culminated in the inhibition of 
the cap-snatching process. It is equally possible that RdRp is recruited to the 
nucleocapsid templates by the N-RdRp interaction during transcription and 
replication of the viral genome. The strong colocalization of the overexpressed 
pol1291–2153 fragment with N protein in virus-infected cells suggests that the 
pol1291–2153 fragment might have competitively blocked the recruitment of wild-








Figure 8 Interaction of N with RdRp.  
(A) Pictorial representation of RdRp mutants used in this study. A conserved 
domain prediction software from NCBI 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) suggested that the catalytic 
domain is located in the region from amino acids 562 to 1286 and the upstream 
intervening region of unknown function corresponds to the region from amino 
acids 238 to 562. (B) HEK293T cells grown on 60-mm-diameter dishes were 
cotransfected with a plasmid expressing myc-tagged wild-type (w.t.) N protein 
along with another plasmid expressing the His-tagged RdRp fragment of interest 
(pol1–250, pol251–752, pol751–1290, pol1291–2153, pol238–562, or pol562–
1286). Cells were lysed 48 h posttransfection, the resulting cell lysates were 
immunoprecipitated (IP) with anti-myc tag antibody, and immunoprecipitated 
material was examined by Western blot (WB) analysis using either anti-His tag 
antibody (panel i) or anti-myc tag antibody (panel ii). The light chain of anti-myc 
antibody is shown in panel iii. Cell lysates were also incubated with Ni-NTA 
beads, and the eluted material from washed beads was examined by Western 
blot analysis using anti-myc tag antibody (panel iv). Equal volumes of whole-cell 
lysates (WCL) were examined by Western blot analysis using either anti-His tag 
antibody (panel v) or anti-myc tag antibody (panel vi) or anti-GAPDH antibody 
(panel vii) or antitubulin antibody (panel viii). The band intensity for β-actin and 
tubulin was quantified and normalized to the last band from the left; the intensity 
is indicated at the bottom. Note that the plasmids used for transfection are shown 
in Table 1. (C) HeLa cells in a 96-well plate at 70% confluence were transfected 
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with 2.5 µg of a plasmid expressing either the pol1–250 fragment or pol 238–562 
fragment. Cell viability was measured 48 h posttransfection using the CellTox 
green cytotoxicity assay. The experiment was performed in duplicates. (D) Both 
pol1–250 and pol1291–2153 fragments were expressed in E. coli and purified 
using Ni-NTA beads. HEK293T cells were transfected with a plasmid expressing 
wild-type N protein. Cells were lysed 48 h posttransfection, and the resulting 
lysates were incubated with 2 µg of the purified RdRp fragment of interest at 4°C 
for 3 h. The lysates were immunoprecipitated with anti-myc tag antibody, and the 
immunoprecipitated material was analyzed by Western blotting using anti-His tag 
antibody to detect the RdRp fragments. (E) Huh7 cells in a 60-mm dish were 
infected with SNV at an MOI of 2. Twenty-four hours postinfection, cells were 
transfected with 2.5 µg of a plasmid expressing the Pol1291–2153 fragment. 
Cells were lysed, the resulting lysates were immunoprecipitated with polyclonal 
anti-N antibody, and the immunoprecipitated material was analyzed by Western 
blot analysis using anti-His antibody to detect the pol1291–2153 fragment 
(bottom). The cell lysates were also incubated with Ni-NTA beads, and the eluted 











Figure 9 Confocal imaging of N and RdRp fragments.  
(A) HeLa cells were grown on a coverslip up to 70% confluence in a 35-mm-
diameter dish. Cells were cotransfected with a plasmid expressing GFP-N fusion 
protein along with another plasmid expressing either the pol238–562 or pol1293–
2153 fragment fused with mCherry. Thirty-six hours posttransfection, cells were 
fixed with 3.7% paraformaldehyde (PFA) and visualized with a Nikon Eclipse 
C1si confocal microscope. Due to the large image size, all images in each row 
were stacked, and the same region was excised for presentation in this figure. 
DAPI, 4′,6-diamidino-2-phenylindole. (B) We next examined the colocalization of 
N protein with pol238–562 and pol1291–2153 fragments in virus-infected cells. 
Vero E6 cells were grown on a coverslip as mentioned above and infected with 
SNV at the MOI of 2. Thirty-six hours postinfection, cells were transfected with 
2.5 µg of plasmid expressing either the pol238–562 or pol1293–2153 fragment 
fused to mCherry. Eighteen hours posttransfection, cells were fixed and 
examined under confocal microscope. N protein was visualized using anti-N 
primary antibody and a secondary antibody conjugated with FITC. In the control 
experiment, rat IgG was used instead of anti-N primary antibody, and the 
secondary antibody was conjugated with FITC, which did not generate any signal 
(not shown). This demonstrates the specificity of anti-N antibody in this assay. 











Figure 10 The RdRp binding domain is located at the N terminus of N. (A) 
Pictorial representation of N deletion mutants used in this work. The deleted 
regions are not shown. (B) HEK293T cells grown on 60-mm-diameter dishes 
were cotransfected with a plasmid (Table 1) expressing FLAG-tagged pol1291–
2153 fragment along with another plasmid expressing the His-tagged wild type 
(w.t.) or N mutant (N51–428, N101–428, N151–428, N176–428 N231–428, N1–
402, N1–346, N1–237, or N1–175). Forty-eight hours posttransfection, cells were 
lysed, the resulting cell lysates were immunoprecipitated (IP) with anti-FLAG 
antibody, and the immunoprecipitated material was examined by Western 
blotting (WB) using either anti-SNV N antibody to detect N mutants (panel i) or 
anti-FLAG antibody to detect pol1291–2153 fragment (panel ii). The heavy chain 
of anti-FLAG antibody is shown in panel iii. The cell lysates were also incubated 
with Ni-NTA slurry (Qiagen), and the eluted material from washed beads was 
examined by Western blotting using anti-FLAG antibody to detect the pol1291–
2153 mutant (panel iv). Equal volumes of whole-cell lysates (WCL) were also 
examined by Western blot analysis using either anti-SNV N antibody (panel v) or 
anti-FLAG tag antibody (panel vi). Note that the plasmids used for transfection 














Figure 11 Overexpression of the pol1291–2153 mutant specifically inhibits 
hantavirus replication in cells.  
(A) Huh7 cells were transfected with 2.5 µg of plasmid expressing either the 
pol1291–2153 or pol751–1290 mutant. Sixteen hours posttransfection, cells were 
infected with SNV at an MOI of 0.5. Thirty-six hours postinfection, cells were 
again transfected to boost the expression of RdRp fragments. Cells were 
harvested at 0, 12, 24, 36, 48, and 72 h postinfection. Total RNA was extracted 
from half of the cells collected at each time point with the RNeasy minikit and 
converted to cDNA using a random primer. S-segment RNA levels were 
quantified by real-time PCR using β-actin as an internal control, as previously 
reported[1, 186] .Fold changes in S-segment RNA levels related to the zero hour 
time point are shown. Fold changes calculated from three independent 
experiments were averaged and used to calculate the standard deviation, shown 
as error bars. The remaining half of the cells were lysed with 1× Laemmli sample 
buffer containing 2% SDS and analyzed by Western blotting using the 
monoclonal anti-His antibody to monitor the expression of RdRp mutants. (B) 
HeLa cells were transfected with 2.5 µg of either empty vector or a plasmid 
expressing the Pol1291–2153 fragment. Cells were infected with vesicular 
stomatitis virus 16 h posttransfection (103 PFU/well in a 24-well plate). Cells 
were harvested at 0, 6, 12, 18, and 24 h postinfection. Half of the cells were used 
for RNA extraction to quantify the VSV genomic RNA levels using real-time PCR. 
Fold changes in vRNA levels were calculated as mentioned in panel A. The 
remaining half of the cells were lysed for Western blot analysis to check the 
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Table 1 Constructs used in this study 
 
To generate His-tagged N mutants, PCR product was generated from pSNVN 
using the appropriate primers listed above. The PCR product was cloned into 
pTriEX 1.1 between the NcoI and XhoI sites. To generate His-tagged RdRp 
mutants, the region of interest was PCR amplified using the appropriate primers 
listed above, and the PCR product was cloned into the pTriEX 1.1 backbone 
between the NcoI and XhoI sites. pCNDA-FLAG was modified from pCDNA3.1(+) 
by annealing the listed primers and inserting the resulting DNA into pCDNA3.1(+) 
between the XhoI and XbaI sites. pPol1291–2153-FLAG was generated from 
pPol1291–2153 using the appropriate primers listed above, and the PCR product 
was cloned into pCDNA-FLAG between NheI and XhoI. To generate pTriEx 
mCherry, the PCR product was generated from pmCherry using the appropriate 
primers listed above. The PCR product was cloned into the pTriEX 1.1 backbone 
between the XhoI and SphI sites. The pPol238–562-mCherry and pPol1291–
2153-mCherry constructs were generated by excising the open reading frame 
(ORF) from pPol238–562 and pPol1291–2153 using the NcoI and XhoI 
firmed the interaction between N protein and the pol1291–2153
fragment (Fig. 1D, top panel). To further confirm this interaction
in virus-infected cells, the cell lysates were immunoprecipitated
with anti-N protein antibody, and immunoprecipitated material
was examined by Western blot analysis using anti-His tag anti-
body. It is evident from Fig. 1E (bottom panel) that N protein
interacts with the pol1291–2153 fragment in virus-infected cells.
To directly visualize the interaction between N protein and the
pol1291–2153 fragment, we fused GFP and mCherry reporters at
the N terminus of N protein and C terminus of the pol1291–2153
fragment, respectively. Similarly, mCherry was also fused at the C
terminus of t e pol238 –562 fragment and used a a negative con-
trol. HeLa cells were cotransfected with plasmids expressing either
the GFP-N fusion protein along with another plasmid expressing
either the pol1291–2153 or pol238 –562 fragment fused to
mCherry. Cells were examined under a confocal microscope. As
shown in Fig. 2A, both RdRp fragments and N protein showed the
perinuclear punctate morphology. The green and red puncta rep-
resenting N protein and the pol1291–2153 fragment strongly co-
localized with each other (Fig. 2A). In comparison, we did not
observe a noticeable colocalization between N protein and the
pol238 –562 fragment (Fig. 2A). These results are consistent with
the specific binding of N protein to the pol1291–2153 fragment.
To visualize the i teraction between N protein and the pol1291–
2153 fragment in virus-infected cells, we infected Vero E6 cells
with SNV at an MOI of 2.0. Thirty-six hours postinfection, cells
were transfected with a plasmid expressing the pol1291–2153
fragment fused to mCherry, as mentioned above. N protein was
visualized in virus-infected cells by confocal microscopy using a
fluorescein isothiocyanate (FITC)-conjugated antibody. As
shown in Fig. 2B, N protein showed a rod-shaped perinuclear
morphology, presumably representing the virion RNPs. Again, a
noticeable colocalization between the pol1291–2153 fragment
and N protein was observed. The expression of RdRp fragments
pol238 –562 or pol1291–2153 does not seem to influence the N
protein morphology in virus-infected cells. These results clearly
demonstrate that N protein interacts with the C-terminal unchar-
acterized fragment of RdRp.
To identify the RdRp binding domain in the N protein, we used
a panel of both the C- and N-terminal deletion mutants of the N
protein (Fig. 3A). All of these mutants contained a C-terminal His
tag. We also modified the pol1291–2153 expression construct
(Fig. 1A) by replacing the C-terminal His tag with a FLAG tag
(Table 1). HEK293T cells were cotransfected with a plasmid ex-
pressing the FLAG-tagged pol1291–2153 fragment along with an-
other plasmid expressing the N mutant of interest. An examina-
tion of whole-cell lysates (WCL) by Western blot analysis using
anti-N protein antibody revealed that expression levels of few N
mutants were weaker than those of other ones (Fig. 3B), although
differential recognition of N protein mutants by anti-SNV N an-
tibody cannot be ruled out. However, the levels of expression of
the FLAG-tagged pol1291–2153 fragment in whole-cell lysates
were relatively similar in all samples. Cell lysates were immuno-
precipitated by anti-FLAG tag antibody, and immunoprecipitated
material was examined by Western blot analysis using anti-N pro-
tein antibody. As shown in Fig. 3B, that deletion of up to 252
amino acids from the C terminus (N1–175 mutant) did not abro-
gate the interaction between N protein and pol1291–2153 frag-
ment. In comparison, the deletion of just 50 amino acids from the
N terminus of N p otein abrogated the interaction. To further
confirm these results, we incubated the cell lysates with Ni-NTA
beads, and the bound material eluted from washed beads was ex-
amined by Western blot analysis using anti-FLAG antibody. It is
evident that unlike the N-terminal deletion mutants, all of the
C-terminal deletion mutants bound to FLAG-tagged pol1291–
2153 fragment, consistent with similar observations from the im-
munoprecipitation experiment. Taken together, these results sug-




pN51-428-His CATGCCATGGTGTCTGCATTGGAGACCAAACTCG TGGTGGTGCTCGAGTTTAAGTGGTTCTTGGTTAGAGATTTCC pTrix1.1
pN101-428-His CATGCCATGGTCCTTGATGTAAATTCCATTGACT TGGTGGTGCTCGAGTTTAAGTGGTTCTTGGTTAGAGATTTCC pTrix1.1
pN151-428-His CATGCCATGGAAAATAAGGGAACAAGAATCCGATT TGGTGGTGCTCGAGTTTAAGTGGTTCTTGGTTAGAGATTTCC pTrix1.1
pN176-428-His CATGCCATGGGACATCTATATGTTTCTATGCCAAC TGGTGGTGCTCGAGTTTAAGTGGTTCTTGGTTAGAGATTTCC pTrix1.1
pN231-428-His CATGCCATGGATTGGATGGAAAGGATTGATGACT TGGTGGTGCTCGAGTTTAAGTGGTTCTTGGTTAGAGATTTCC pTrix1.1
pN1-175-His CTAGCCATGGGCACCCTCAAAGAAGTGCAAG TATAATCTCGAGTGGCTTACGTATTCCATTAACT pTrix1.1
pN1-237-His CTAGCCATGGGCACCCTCAAAGAAGTGCAAG TATAATCTCGAGATCATCCTTGAATCGGATTCTT pTrix1.1
pN1-346-His CTAGCCATGGGCACCCTCAAAGAAGTGCAAG TATAATCTCGAGAGATTTTGATGCCATTATGGTG pTrix1.1
pN1-402-His CTAGCCATGGGCACCCTCAAAGAAGTGCAAG TATAATCTCGAGATCCATATCATCTCCAAGATGG pTrix1.1
pPol1–250 ATAATATCCATGGAGAAGTACCGCGAGATCC ATAATATCTCGAGCCAGTGCTTGCAGTACTGGATCAGG pTrix1.1
pPol251–752 ATAATATCCATGGTGACCGAGGATCACGATTTCGTGTTC ATAATATCTCGAGCGGGCCCACTCCACGGTC pTrix1.1
pPol751–1290 ATAATATCCATGGCCCGCAAGTTCGAGGCCAAG ATAATATCTCGAGGCCTTCACGCAGCGGCTCTG pTrix1.1
pPol1291–2153 ATAATATCCATGGCCTTCTACAGCTACAAGCACACCC ATAATATCTCGAGGTAGAAGCTGCTCACGGGATC pTrix1.1
pPol238–562 ATATATCCATGGCGCCCGAGATCACCAACCTGATCCAGT ATATATCTCGAGGATGCTCATGACCTTGCTGAAGCAC pTrix1.1






pPol1291–2153-FLAG ATAATATGCTAGCGCCTTCTACAGCTACAAGCACACCC ATAATATCTCGAGGTAGAAGCTGCTCACGGGATC pCDNA-FLAG
pTriEx-mCherry TATAATCTCGAGGTGAGCAAGGGCGAGGAGGATAACAT TAATATGCATGCTTACTTGTACAGCTCGTCCATGCCG pTriEx1.1
a To generate His-tagged N mutants, PCR product was generated from pSNVN using the appropriate primers listed above. The PCR product was cloned into pTriEX 1.1 between
the NcoI and XhoI sites. To generate His-tagged RdRp mutants, the region of interest was PCR amplified using the appropriate primers listed above, and the PCR product was
cloned into the pTriEX 1.1 backbone between the NcoI and XhoI sites. pCNDA-FLAG was modified from pCDNA3.1(!) by annealing the listed primers and inserting the resulting
DNA into pCDNA3.1(!) between the XhoI and XbaI sites. pPol1291–2153-FLAG was generated from pPol1291–2153 using the appropriate primers listed above, and the PCR
product was cloned into pCDNA-FLAG between NheI and XhoI. To generate pTriEx mCherry, the PCR product was generated from pmCherry using the appropriate primers
listed above. The PCR product was cloned into the pTriEX 1.1 backbone between the XhoI and SphI sites. The pPol238 –562-mCherry and pPol1291–2153-mCherry constructs
were generated by excising the open reading frame (ORF) from pPol238 –562 and pPol1291–2153 using the NcoI and XhoI restriction enzymes. The excised ORF was cloned into
pTriEx-mCherry between the same restriction sites.
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restriction enzymes. The excised ORF was cloned into pTriEx-mCherry between 




Conclusions and Discussion 
With the negative strand RNA viruses such as Orthomyxoviridae (e.g., 
influenza viruses and Thogoto viruses), Bunyaviridae (e.g., La Crosse virus, 
Hantavirus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever viruse) 
and Arenaviridae (e.g., Lassa virus) family members, viral mRNA synthesis is 
initiated by a cap-snatching mechanism, which uses host capped mRNA as 
primers for mRNA synthesis [176, 177]. In hantavirus, transcription initiates 
through a “prime-and-realign” mechanism, in which a guanine residue from a cap 
donor undergo base-paring with a cysteine residues at the 3’ terminus of a vRNA 
segment [37, 69]. The initial alignment is followed by cleavage of cap donor after 
annealing site (G) and subsequent synthesis of nascent viral mRNA.  However, 
not all guanine-containing capped-oligos are used as cap-donor equally. 
Sequencing studies showed non-viral leading sequence of bunyavirus mRNA is 
most ranging from 10-20 nucleotides long [157, 158]. Thus, it remains a mystery 
of how cap-donors are selected and processed by hantavirus. Our studies on 
hantavirus cap-snatching using test capped transcripts as cap-donor has 
revealed several characteristics of a preferred cap donor for the virus to prime its 
transcription. First, the cap donor is preferentially used by virus when the guanine 
residues that would anneal to the viral RNA is located around 14 nucleotides 
downstream of the 5’ cap. Second, there is a positive correlation between the 
cap-snatching efficiency and sequence complementarity of the nucleotides on 
 97 
the capped oligo and the 3’ terminus of vRNA. These observations suggests that 
there is a specific selection of cap donors by hantavirus, which is strongly 
contributed by the annealing strength of vRNA and cap donor mRNAs. 
The hantavirus replication cycle is confined to the cytoplasm.  Therefore, the 
vRNPs have to effectively compete with the host mRNA processing machinery 
including those involve in translation and mRNA decay in order to acquire 
sufficient capped mRNA to be used as primers.  
Our study observed that virus preferentially snatch caps from a PTC-containing 
mRNA. Moreover, we found the mRNA engaged in translation may not be a 
strong cap donor even if it contains one or more complementary nucleotides to 
the 3′ terminus of the viral RNA template at the appropriate position. We 
observed hantavirus has extremely poor cap-snatching efficiency on its own 
mRNA, which possess highest complementarity to the vRNA; unless it contains a 
PTC. These findings suggest that hantaviruses prefers to use mRNAs that are 
not engaged in translation as primers for transcription. 
P-bodies are the intracellular loci where non-translating mRNAs are stored 
and degraded. Hantavirus N proteins actively protect the host mRNA caps from 
degradation, possibly through competing with the decapping machinery [37, 194]. 
The N protein has been shown to localize with the P-body, indicating a possible 
role of P-body in hantavirus life cycle.  
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Our study showed that when P-body is disrupted by knocking down of its 
structural components, the steady state level of a non-translating mRNAs is 
elevated, resulting a larger cap-donor pool in the cytoplasm. However, the virus 
does not snatch caps better from these mRNAs. P-bodies might be a preferred, 
but not the only site for cap-snatching.  A possible explanation is that in the P-
body, the local concentration of ribosome free capped RNA is much higher than 
that in the cytoplasm, thus it would be easier for the N or vRNP to recognize and 
align to the potential cap-donor mRNA. When P-body is disassembled, more 
RNAs are available as cap-donors, but the total concentration of ribosome-free 
capped mRNAs does not increase significantly, because the foci where the 
ribosome free mRNAs accumulate, is lost. Further experimentation is required to 
demonstrate the exact role of cellular P bodies in the cap-snatching process.  
Similar characteristics of cap donors are also observed in influenza virus 
cap-snatching. First, influenza virus shows a clear preference for cap-donors 
harboring a 3’ CGA sequence, and the optimal non-viral primer length appears to 
be 10-11 nucleotides [63]. Second, while base-pairing is a preferred determinant 
for cap donor selection,  the cap-snatching efficiency do not further increase 
when base-paring is greater than 3 [63]. (Table 2) However, the cellular loci of 
cap-snatching for influenza virus is different. Transcription of influenza virus 





Table 2. Comparison of requirements for a preferred cap-snatching primer 










 Hantavirus Influenza virus 
Preferred snatching site G AG 
Complementarity correlating to 
cap-snatching efficiency 
9 or over Up to 3 
Source of cap donor Cellular 
mRNAs 
Pre-mRNAs 







Another mystery in hantavirus cap-snatching mechanism is that how 
vRNP selects and processes the cap donor RNA in a highly selective fashion. It 
is known that the capped mRNA are cleaved at the guanine residues 10-20 
nucleotides from the 5’ cap with 14th guanine the most preferred cleavage site. 
In contrast, the endonuclease domain of the bunyaviridae RdRp has been 
demonstrated to be sequence non-specific [52]. Thus, we speculated that the 
RdRp within the vRNP must be restrained to the 5’ of cap donor RNA possibly 
the cap to achieve selectivity on the position of the guanine. However, cap-
binding ability has not been described with the bunyavirus RdRp [52]. Since the 
hantavirus N protein is able to the bind cap, we proposed that N might load the 
RdRp to the mRNA and restrain it at the vicinity to the 5’ cap. Our study revealed 
that N is able to bind to the C-terminal portion of the RdRp, and the binding is 
independent of RNA, as an N mutant lacking RNA binding domain is also able to 
bind RdRp. In addition, we showed that the binding between RdRp C-terminal 
fragment and N protein is specifically important to hantavirus, as overexpression 
of the RdRp C-terminal fragment significantly reduced the level of hantavirus 
RNA produced, but not other negative strand RNA viruses. A possible 
explanation is that the wild type RdRp is expressed in the viral infected cells at 
negligible level and would be outcompeted by the overexpressed C-terminal 
fragment for N protein binding. However, it is not possible to distinguish whether 




Studies in other virus systems also supported our speculation that RdRp 
interacts with cap, possibly bridged by nucleocapsid protein, might contributes 
the specificity of the hantavirus RdRp endonuclease cleavage during cap-
snatching. It is thought that the cap-binding RdRp subunit of influenza virus, PB2, 
may play an important role in contributing the specific cleavage of mRNA 
substrate [64, 66, 68]. Both activity and sequence specificity of the endonuclease 
is significantly higher in the viral RNA than PA itself.  This ssuggests a critical 
role of cap-binding mediated distance measurement from the 5’ end of the RNA 
that contributes to the specificity of the influenza polymerase endonuclease.[68] 
However, in case of hantavirus we have not yet demonstrated  whether N-
RdRp binding contributes to the specific cleavage of the capped donor in 
hantavirus as the full-length hantavirus RdRp cannot be expressed at a 
detectable level for purification.  Therefore, further in vitro study using purified 
full-length RdRp is required to demonstrate the interaction between N and RdRp 
and its role in the specific cleavage of mRNA by the RdRp endonuclease. 
Taken together, we propose a model of a possible mechanism by which 
hantavirus achieves cap donor selection and specific cleavage (Fig. 1) This 
proposed model suggests a novel mechanism of cap-snatching in bunyaviridae 
family viruses. More importantly, our study revealed novel anti-targets against 









Figure 12 A proposed model for hantavirus cap-snatching mechanism 
The specific cap-snatching is proposed to go through the following steps: (A) N 
binds to the 5’ cap of the cap donor RNA and protects it from degradation. (B) 
RdRp associated with viral RNP is loaded to the cap donor through N-RdRp 
interaction. (C) vRNP scans the cap donor RNA in a 5’ to 3’ fashion for 
nucleotides complimentary to 3’ terminus (predominantly G residue) and followed 
by base-paring annealing of vRNA and cap donor. The range of distance of 
guanine residue is limited due to the size and flexibility of the RdRp protein. (D) 
vRNP cleaves cap-donor after the annealing sequence. Only cap donor is 
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